Other and unspecified effects of external causes

ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T66-T78 Cause of death: ICD-10 — T66-T78 2 out of 7 registries used, show all original rules.	14106
4. Check minimum number of events None	14106
5. Include endpoints ST19_UNSPE_EFFEC_RADIATION ST19_EFFEC_HEAT_LIGHT ST19_HYPOTHERMIA ST19_OTHER_EFFEC_REDUCED_TEMPE ST19_EFFEC_AIR_PRESSURE_WATER_PRESSURE ST19_ASPHYXIATION ST19_EFFEC_OTHER_DEPRI ST19_MALTR_SYNDR ST19_EFFEC_OTHER_EXTER_CAUSES ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED	14106
6. Filter based on genotype QC (FinnGen only)	13429

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: S|T
Name in latin: Effectus causarum externarum aliarum sive non specificatarum

NAME	ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	ST19_UNSPE_EFFEC_RADIATION\|ST19_EFFEC_HEAT_LIGHT\|ST19_HYPOTHERMIA\|ST19_OTHER_EFFEC_REDUCED_TEMPE\|ST19_EFFEC_AIR_PRESSURE_WATER_PRESSURE\|ST19_ASPHYXIATION\|ST19_EFFEC_OTHER_DEPRI\|ST19_MALTR_SYNDR\|ST19_EFFEC_OTHER_EXTER_CAUSES\|ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T6[6-9]\|T7[0-8]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T6[6-9]\|T7[0-8]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified effects of external causes based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	13429	8541	4888
Unadjusted period prevalence (%)	2.74	3.03	2.24
Median age at first event (years)	45.54	43.17	49.68

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
14106: Matched controls
141060

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.3

314.3

1317

4321

L50.8

ICD-10 Finland

Other urticaria

6.7

307.7

600

925

T75.4

ICD-10 Finland

Effects of electric current

81.6

307.7

995

131

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

327.1

307.7

1922

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

334.7

307.7

327

W84

ICD-10 Finland

Unspecified threat to breathing

65.1

307.7

281

T74.1

ICD-10 Finland

Physical abuse

38.5

307.7

2230

685

T78.3

ICD-10 Finland

Angioneurotic oedema

194.4

307.7

2131

129

X58

ICD-10 Finland

Exposure to other specified factors

3.1

307.7

3148

12137

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

33.4

307.7

780

247

L50.0

ICD-10 Finland

Allergic urticaria

5.8

307.7

880

1599

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

307.7

5980

38124

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

18.0

307.7

1305

796

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

5.0

307.7

980

2062

R06AE07

ATC

cetirizine; oral

2.4

307.7

7763

47994

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

97.3

307.7

173

H02AB06

ATC

prednisolone; systemic

2.9

307.7

8154

45012

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

7.6

307.7

544

744

A92

ICPC

Allergy/allergic reaction NOS

4.3

307.7

890

2169

X59

ICD-10 Finland

Exposure to unspecified factor

3.7

307.7

4528

16073

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

4.2

307.7

2597

7254

C01CA24

ATC

epinephrine; parenteral

15.0

307.7

4333

4053

X57

ICD-10 Finland

Unspecified privation

8.5

307.7

866

1078

XQ800

NOMESCO Finland

Prick test

5.6

307.7

2707

5775

W86

ICD-10 Finland

Exposure to other specified electric current

24.0

307.7

447

192

L50.9

ICD-10 Finland

Urticaria, unspecified

4.7

307.7

1135

2559

T68

ICD-10 Finland

Hypothermia

673.6

307.7

704

T78.4

ICD-10 Finland

Allergy, unspecified

69.7

307.7

6517

1717

R03AC02

ATC

salbutamol; inhalant

1.9

307.5

8377

60537

J45.9

ICD-10 Finland

Asthma, unspecified

2.3

307.4

3048

15361

S06.0

ICD-10 Finland

Concussion

2.6

307.0

2029

8524

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.7

304.8

1831

7333

R06AX27

ATC

desloratadine; oral

2.0

297.2

5040

30990

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

9.3

294.3

357

393

N02AX02

ATC

tramadol; systemic, rectal

1.9

283.5

5845

38208

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

278.5

5895

38801

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.5

272.5

1015

3087

AA1AD

NOMESCO Finland

CT of head and brain

2.1

271.0

3484

19306

R06.0

ICD-10 Finland

Dyspnoea

2.0

264.8

3681

20956

R51.80

ICD-10 Finland

Headache

2.1

257.9

2840

14809

H02AB07

ATC

prednisone; oral

2.4

251.2

2046

9411

N05AH04

ATC

quetiapine; oral

2.1

250.7

3058

16556

Y04.0

ICD-10 Finland

Assault by bodily force by spouse or partner

13.1

250.1

239

185

X31

ICD-10 Finland

Exposure to excessive natural cold

28.3

245.7

165

T74.2

ICD-10 Finland

Sexual abuse

49.1

243.6

141

Y09

ICD-10 Finland

Assault by unspecified means

12.1

240.1

241

202

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

234.8

2442

12406

N05BA04

ATC

oxazepam; oral

1.9

231.0

3844

23098

M79.6

ICD-10 Finland

Pain in limb

1.8

230.3

5989

41280

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.6

229.2

798

2318

R06AE09

ATC

levocetirizine; oral

2.1

229.1

2520

13072

A02BC02

ATC

pantoprazole; systemic

1.8

223.9

8967

69741

N03AX16

ATC

[U] pregabalin

2.0

223.6

3188

18155

Z3231

NOMESCO Finland

Registered nurse

1.9

221.9

3914

23913

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

221.0

4069

25194

R03DC03

ATC

montelukast; oral

2.1

218.8

2695

14559

J01FF01

ATC

clindamycin; systemic

1.9

218.7

3882

23747

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

217.8

3917

24054

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

217.3

3631

21776

Y96.9

ICD-10 Finland

Unspecified type of accident

5.2

214.6

449

884

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

17.4

210.1

172

100

N06AX11

ATC

mirtazapine; oral

1.8

205.9

4808

31845

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

205.4

3716

22791

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

3.6

199.2

698

2033

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

197.1

2834

16101

X27

ICD-10 Finland

Contact with other specified venomous animals

31.2

195.3

127

N05BA01

ATC

diazepam; systemic, rectal

2.2

194.6

1868

9140

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

193.7

3035

17730

Y07

ICD-10 Finland

Other maltreatment

7.7

191.6

269

354

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.4

191.3

488

1132

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

189.3

1874

9275

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

188.4

2716

15416

R60.0

ICD-10 Finland

Localized oedema

2.3

182.2

1617

7651

M54.5

ICD-10 Finland

Low back pain

1.7

182.0

5195

36078

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

179.2

1990

10279

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

8.6

177.3

228

270

N02BE01

ATC

paracetamol; systemic, rectal

2.0

175.5

12189

107009

R02

ICPC

Shortness of breath/dyspnoea

2.1

174.3

1843

9338

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

173.9

2641

15207

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

6.6

170.4

276

425

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

5.0

170.1

369

749

T67.0

ICD-10 Finland

Heatstroke and sunstroke

63.1

170.1

N06AB04

ATC

citalopram; systemic

1.8

169.7

2909

17394

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

169.1

2597

14993

Y34

ICD-10 Finland

Unspecified event, undetermined intent

8.8

168.6

212

244

T70.0

ICD-10 Finland

Otitic barotrauma

22.6

168.6

123

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

164.0

2001

10673

Z51.6

ICD-10 Finland

Desensitization to allergens

4.9

163.8

371

781

R06AX22

ATC

ebastine; oral

1.9

163.6

2610

15237

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

163.3

2051

11052

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.4

163.0

1244

5506

R42

ICD-10 Finland

Dizziness and giddiness

1.8

160.5

2886

17474

R03BA02

ATC

budesonide; inhalant

1.9

159.1

2613

15382

L27.2

ICD-10 Finland

Dermatitis due to ingested food

5.5

158.7

313

584

J01DB01

ATC

cefalexin; oral

1.8

157.2

11618

101331

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

156.6

5894

43432

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

154.9

1235

5567

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.3

154.3

411

985

XQ802

NOMESCO Finland

Epicutan test

2.9

153.2

764

2742

R53

ICD-10 Finland

Malaise and fatigue

1.7

152.7

3402

21877

Y19

ICD-10 Finland

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

12.4

152.2

150

122

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

151.5

3801

25237

N06AX16

ATC

venlafaxine; oral

1.9

150.5

2251

12837

R03BA05

ATC

fluticasone; inhalant

1.8

149.8

2710

16398

T63.4

ICD-10 Finland

Toxic effect: Venom of other arthropods

5.8

148.6

276

487

P01AB01

ATC

metronidazole; oral, rectal

1.6

146.0

5391

39349

N05CF01

ATC

zopiclone; oral

1.7

145.6

3869

26028

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

145.3

5752

42664

XQ820

NOMESCO Finland

Exposure to medicinal substance

10.0

144.6

165

167

P15

ICPC

Chronic alcohol abuse

3.3

144.0

553

1704

Y04.2

ICD-10 Finland

Assault by bodily force by friend

12.1

143.0

143

119

Z71.8

ICD-10 Finland

Other specified counselling

1.6

141.0

4527

31883

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

140.3

2483

14892

J01AA02

ATC

doxycycline; systemic

1.6

140.1

9991

84548

N03AX12

ATC

[U] gabapentin; oral

1.9

139.9

2128

12176

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.5

139.9

351

803

G44.2

ICD-10 Finland

Tension-type headache

1.9

139.8

2107

12022

J01MA02

ATC

ciprofloxacin; systemic

1.6

138.8

4683

33350

R06AX13

ATC

loratadine; oral

1.8

138.7

2356

13951

E0000UV, ,

ATC

1.6

138.6

5814

43554

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

138.2

1480

7498

N06AX21

ATC

duloxetine; oral

2.0

138.0

1727

9256

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.8

137.9

437

1187

N07BB01

ATC

disulfiram; oral

2.8

137.5

719

2645

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

135.4

707

2598

J01MA12

ATC

levofloxacin; systemic

1.8

134.8

2195

12819

L50.3

ICD-10 Finland

Dermatographic urticaria

4.0

133.3

387

988

H02AB04

ATC

methylprednisolone; systemic

1.9

132.9

1894

10598

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

131.6

7756

62377

G43.9

ICD-10 Finland

Migraine, unspecified

2.2

131.5

1150

5376

X39

ICD-10 Finland

Exposure to other and unspecified forces of nature

24.0

130.6

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

130.6

2782

17563

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

130.0

1508

7858

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

129.6

1420

7246

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.0

129.6

602

2075

L20.0

ICD-10 Finland

Besnier prurigo

2.1

129.0

1394

7076

A02BC05

ATC

esomeprazole; systemic

1.6

128.9

5062

37183

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.6

128.5

434

1231

M25.5

ICD-10 Finland

Pain in joint

1.6

128.1

4375

31111

S18

ICPC

Laceration/cut

1.5

126.6

5562

41840

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

126.6

3007

19529

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

125.3

3033

19790

M03BX02

ATC

tizanidine; oral

1.5

125.2

8314

68268

C07AB07

ATC

bisoprolol; oral

1.6

124.8

5051

37284

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

124.4

1837

10382

L03

ICPC

Low back symptom/complaint

1.6

123.9

3806

26352

R11

ICD-10 Finland

Nausea and vomiting

2.1

123.2

1306

6577

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

123.0

1742

9711

Y88.0

ICD-10 Finland

Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use

15.1

122.9

108

R60.9

ICD-10 Finland

Oedema, unspecified

2.6

122.3

751

2995

N06AB10

ATC

escitalopram; oral

1.7

122.1

3192

21222

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.9

122.1

1786

10059

XQ801

NOMESCO Finland

Intracutantest

8.0

121.5

164

206

W19

ICD-10 Finland

Unspecified fall

2.1

121.4

1348

6905

T75.1

ICD-10 Finland

Drowning and nonfatal submersion

1189.0

121.0

118

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

120.9

1964

11429

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.8

120.5

372

992

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

120.4

6596

51829

N03AX09

ATC

lamotrigine; oral

2.4

119.7

889

3872

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

119.2

2704

17312

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.8

119.1

1876

10811

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

117.9

1829

10487

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

117.0

1673

9346

N05AH03

ATC

olanzapine; systemic

2.2

116.7

1021

4767

C07AA05

ATC

propranolol; systemic

1.7

116.4

2912

19113

J45

ICD-10 Finland

Asthma

2.0

116.3

1507

8145

T73.3

ICD-10 Finland

Exhaustion due to excessive exertion

28.0

115.7

Y98

ICD-10 Finland

Lifestyle-related condition

12.5

115.3

113

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

114.8

1201

6012

SPAT1254

SPAT

Administration of medicine

1.8

114.0

1978

11726

R96

ICPC

Asthma

2.0

113.6

1314

6823

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

113.4

1792

10325

F10.24

ICD-10 Finland

Alcohol depence active use

4.3

112.5

299

715

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

112.0

3116

20975

N03AG01

ATC

valproic acid; systemic, rectal

2.3

111.8

913

4140

N03AE01

ATC

clonazepam; systemic

2.4

110.8

802

3451

N06AB06

ATC

sertraline; oral

1.8

110.6

1759

10150

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

110.3

4260

30917

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

109.7

2766

18157

M79.1

ICD-10 Finland

Myalgia

1.8

109.6

2073

12593

R03AC03

ATC

terbutaline; inhalant

1.8

109.0

1926

11468

R06.4

ICD-10 Finland

Hyperventilation

3.9

107.8

328

866

J46

ICD-10 Finland

Status asthmaticus

3.1

107.7

466

1541

R01AD09

ATC

mometasone; nasal

1.5

107.5

6283

49609

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

106.3

9961

86321

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

105.7

5748

44687

J01DA01

ATC

[U] cefalexin

1.5

105.6

8088

67239

A01

ICPC

Pain general/multiple sites

2.0

105.5

1215

6294

R50.9

ICD-10 Finland

Fever, unspecified

1.7

105.4

2044

12491

D07AA02

ATC

hydrocortisone; topical

1.7

105.3

2102

12951

J01FA06

ATC

roxithromycin; oral

1.5

105.1

4918

37084

Z3226

NOMESCO Finland

Physiotherapist

1.7

105.0

2274

14325

P01

ICPC

Feeling anxious/nervous/tense

1.7

104.9

2229

13971

R55

ICD-10 Finland

Syncope and collapse

2.0

104.5

1298

6902

D11

ICPC

Diarrhoea

1.8

104.4

1865

11131

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

14.9

104.0

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

103.7

786

3450

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

103.5

1015

4951

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

103.1

1765

10399

R4110

NOMESCO Finland

Physiotherapy

1.6

102.9

3330

23162

R05

ICPC

Cough

1.6

102.1

3236

22393

XQ899

NOMESCO Finland

Other assessment of skin

8.2

101.3

135

167

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

100.4

3331

23278

L50.1

ICD-10 Finland

Idiopathic urticaria

5.7

100.3

189

338

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.6

100.1

583

2262

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.5

100.1

675

2810

R01AD08

ATC

fluticasone; nasal

1.5

99.9

3883

28093

W69

ICD-10 Finland

Drowning and submersion while in natural water

31.1

99.6

L17

ICPC

Foot/toe symptom/complaint

1.5

99.6

3601

25645

T78.9

ICD-10 Finland

Adverse effect, unspecified

174.6

99.4

104

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

99.0

668

2781

J01FA10

ATC

azithromycin; systemic

1.5

98.2

8164

68490

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

97.9

1183

6225

Z00.8

ICD-10 Finland

Other general examinations

2.0

97.5

1142

5945

ZXE00

NOMESCO Finland

One hour or less

1.5

97.4

4958

37869

P29

ICPC

Psychological sympt/compl other

1.9

96.9

1247

6705

A03

ICPC

Fever

1.6

96.9

2678

17914

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

96.7

7456

61590

C03CA01

ATC

furosemide; systemic

1.6

96.4

2620

17453

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

96.1

1208

6442

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.2

95.7

844

3946

N05BA12

ATC

alprazolam; oral

1.9

95.1

1268

6898

A02BC01

ATC

omeprazole; systemic

1.6

94.6

3222

22601

R74

ICPC

Upper respiratory infection acute

1.5

94.3

4984

38284

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

94.2

3759

27286

R03BB04

ATC

tiotropium bromide; inhalant

2.0

94.1

1043

5320

N05AX08

ATC

risperidone; systemic

2.0

93.9

1033

5255

D01

ICPC

Abdominal pain/cramps general

1.7

93.5

1778

10780

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

92.6

1038

5315

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

92.6

2776

18903

A46

ICD-10 Finland

Erysipelas

1.8

92.4

1573

9234

N05AA02

ATC

levomepromazine; systemic

2.6

92.4

562

2227

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.6

92.3

573

2293

SPAT1240

SPAT

Therapeutic discussion

1.7

91.9

1753

10632

WX892

NOMESCO Finland

Monitored bed care

2.1

91.7

919

4515

B18.2

ICD-10 Finland

Chronic viral hepatitis C

4.1

91.7

255

631

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.8

91.3

282

752

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

91.2

3205

22611

N06AB03

ATC

fluoxetine; oral

1.8

90.9

1630

9713

UJF32

NOMESCO Finland

Coloscopy

1.6

90.9

2845

19558

D07AB08

ATC

desonide; topical

1.8

90.4

1471

8517

P19

ICPC

Drug abuse

4.2

90.3

241

578

S29

ICPC

Skin symptom/complaint other

1.6

89.9

2387

15778

R52.9

ICD-10 Finland

Pain, unspecified

1.9

89.6

1302

7278

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

89.1

10113

89107

N02AA05

ATC

oxycodone; systemic

1.7

89.0

1711

10395

T78.8

ICD-10 Finland

Other adverse effects, not elsewhere classified

304.4

88.8

D07AC01

ATC

betamethasone; topical

1.5

88.6

4418

33452

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

88.5

1114

5938

R07.3

ICD-10 Finland

Other chest pain

1.9

88.3

1246

6898

S80.0

ICD-10 Finland

Contusion of knee

2.0

88.2

1099

5837

L12

ICPC

Hand/finger symptom/complaint

1.6

87.9

2195

14286

M79.7

ICD-10 Finland

Fibromyalgia

2.5

87.6

552

2225

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

87.0

1333

7571

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.0

86.8

980

5029

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.3

86.5

698

3143

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

86.5

774

3637

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

86.2

4192

31551

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

86.0

1224

6793

L28

ICPC

Limited function/disability (L)

1.7

85.9

1792

11125

Y59

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances

4.9

85.4

190

394

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.9

85.4

190

394

Z00.0

ICD-10 Finland

General medical examination

1.6

85.4

2499

16885

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

85.2

1344

7702

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

85.0

4502

34417

Z2221

NOMESCO Finland

Medical doctor

1.5

84.6

3497

25463

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

84.5

1257

7073

A04

ICPC

Weakness/tiredness general

1.7

84.3

1966

12563

E000001, ,

ATC

1.6

84.2

2690

18535

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

83.5

3083

21919

M01AB05

ATC

diclofenac; systemic, rectal

1.4

83.3

8310

70999

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

83.3

926

4724

N05AX12

ATC

aripiprazole; systemic

2.2

83.1

716

3312

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.2

82.9

733

3426

N30.0

ICD-10 Finland

Acute cystitis

1.6

82.9

2106

13747

ZY010

NOMESCO Finland

Hospital outpatient

2.1

82.8

860

4278

Y96.8

ICD-10 Finland

Other type of accident

5.2

82.2

170

331

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

82.2

2900

20409

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

82.1

1326

7649

A02BA02

ATC

ranitidine; systemic

1.6

82.0

1988

12821

C08CA01

ATC

amlodipine; oral

1.5

82.0

3616

26644

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.6

81.9

196

432

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

81.6

1057

5685

N05BB01

ATC

hydroxyzine; systemic

2.0

81.2

876

4418

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.3

81.1

312

961

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

81.1

1870

11907

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

81.0

809

3966

N05AF03

ATC

chlorprothixene; systemic

2.8

80.3

406

1464

Z2446

NOMESCO Finland

Social worker

2.0

79.4

947

4949

WQ000

NOMESCO Finland

Hyposensibilisation

5.1

78.9

167

332

WX002

NOMESCO Finland

Sedation and analgesia

1.6

78.8

2133

14122

H01

ICPC

Ear pain/earache

1.7

78.6

1735

10915

X48

ICD-10 Finland

Accidental poisoning by and exposure to pesticides

42.9

78.4

A02BC03

ATC

lansoprazole; oral

1.5

78.1

3106

22380

R21

ICPC

Throat symptom/complaint

1.5

77.7

3410

25055

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.5

77.4

518

2147

ZXD05

NOMESCO Finland

Urgent procedure

1.5

77.3

3833

28827

Y94.0

ICD-10 Finland

Accident at home

3.4

77.3

279

826

N01

ICPC

Headache

1.6

76.3

1850

11917

R03BA01

ATC

beclometasone; inhalant

1.7

76.2

1693

10664

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.4

76.1

280

839

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

5.1

76.1

161

320

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

76.0

1174

6675

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

75.7

1729

10966

R00.2

ICD-10 Finland

Palpitations

1.9

75.7

1076

5959

Z25

ICPC

Assault/harmful event problem

4.4

75.7

192

443

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

3.1

75.7

332

1106

S01.0

ICD-10 Finland

Open wound of scalp

2.0

75.5

906

4743

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.6

75.5

446

1741

J02AC01

ATC

fluconazole; systemic

1.4

75.3

5149

40982

Y87.1

ICD-10 Finland

Sequelae of assault

20.4

74.9

T67.5

ICD-10 Finland

Heat exhaustion, unspecified

38.5

74.7

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.3

74.2

601

2709

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.5

73.8

476

1939

N05CD07

ATC

temazepam; oral

1.8

73.5

1105

6226

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

73.4

2077

13873

P03

ICPC

Feeling depressed

1.7

73.0

1646

10399

SPAT1263

SPAT

Sampling

1.4

73.0

5415

43624

R52.2

ICD-10 Finland

Other chronic pain

2.4

72.8

501

2102

K30

ICD-10 Finland

Functional dyspepsia

1.7

72.6

1429

8709

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.4

72.5

264

786

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

72.4

1101

6225

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

72.3

3110

22708

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

72.2

1003

5512

Z72.2

ICD-10 Finland

Drug use

4.9

71.8

157

321

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

71.5

1118

6375

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

71.5

7039

59312

P16

ICPC

Acute alcohol abuse

3.2

71.0

280

876

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

70.9

1132

6494

SPAT1260

SPAT

Consultation of another employee

1.6

70.5

2136

14482

J01FA09

ATC

clarithromycin; systemic

1.4

70.2

3973

30505

G47.3

ICD-10 Finland

Sleep apnoea

1.5

70.1

2534

17847

N05CF02

ATC

zolpidem; oral

1.6

69.8

2122

14392

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

69.8

1401

8580

P76

ICPC

Depressive disorder

1.8

69.7

1052

5933

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

69.6

859

4537

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

69.6

2254

15502

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.2

69.5

184

439

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

6.2

69.5

118

191

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

69.4

894

4792

J30.3

ICD-10 Finland

Other allergic rhinitis

2.3

69.3

574

2610

N17

ICPC

Vertigo/dizziness

1.7

69.2

1376

8405

M01AE02

ATC

naproxen; oral, rectal

1.4

68.4

7488

63964

R01AD58

ATC

fluticasone, combinations; nasal

1.4

68.4

3445

25877

EBA00

NOMESCO Finland

Extraction of tooth

1.4

68.3

4723

37488

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

68.3

1112

6415

D07AC13

ATC

mometasone; topical

1.4

68.2

3456

25984

N06AA09

ATC

amitriptyline; systemic

1.8

68.2

1018

5721

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

68.1

459

1908

K02.1

ICD-10 Finland

Caries of dentine

1.4

68.0

8200

71084

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

68.0

966

5345

J01EA01

ATC

trimethoprim; systemic

1.5

67.9

3089

22757

K10.3

ICD-10 Finland

Alveolitis of jaws

2.0

67.8

727

3655

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

67.4

1421

8813

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

67.1

3692

28162

R01AD12

ATC

fluticasone furoate; nasal

1.4

67.0

4367

34293

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

66.9

814

4278

SPAT1283

SPAT

Restricted health certificate

1.5

66.5

2907

21241

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

66.5

1354

8318

L01

ICPC

Neck symptom/complaint

1.6

66.3

2012

13627

SPAT1310

SPAT

Counselling related to known health issue

1.4

66.3

3971

30730

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

66.2

2524

17947

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

66.0

657

3213

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

65.9

906

4959

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.5

65.6

229

664

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

65.5

1310

8008

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.2

65.5

583

2730

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

65.1

626

3020

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

65.0

1104

6446

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.2

64.5

582

2740

M01AH05

ATC

etoricoxib; oral

1.4

64.3

7668

66079

A29

ICPC

General symptom/complaint other

1.7

64.3

1411

8836

WX290

NOMESCO Finland

Other blockage of nerve

1.4

64.2

6669

56278

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

64.2

732

3761

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

64.1

2649

19128

R06.2

ICD-10 Finland

Wheezing

2.1

64.0

613

2954

J01MA14

ATC

moxifloxacin; systemic

1.8

63.9

1001

5704

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

2.9

63.9

310

1093

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.3

63.6

505

2256

J20

ICD-10 Finland

Acute bronchitis

1.7

63.6

1263

7704

Y08.8

ICD-10 Finland

Assault by other specified means by other known person

16.6

63.3

R03AK08

ATC

formoterol and beclometasone; inhalant

2.2

63.1

565

2651

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

62.9

4020

31390

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.6

62.8

210

592

Y94.8

ICD-10 Finland

Other leisure activity accident

2.5

62.7

400

1620

L15

ICPC

Knee symptom/complaint

1.5

62.4

2767

20240

A06AD11

ATC

lactulose; oral

1.7

62.3

1393

8762

D10

ICPC

Vomiting

1.8

62.1

1022

5909

N06AX12

ATC

bupropion; oral

1.7

62.1

1111

6581

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

61.5

5733

47479

R13

ICD-10 Finland

Dysphagia

1.9

61.2

754

3978

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

61.1

3494

26747

J45.8

ICD-10 Finland

Mixed asthma

2.4

61.0

416

1738

Z2445

NOMESCO Finland

Psychologist

2.1

61.0

641

3197

P74

ICPC

Anxiety disorder/anxiety state

2.0

60.8

721

3755

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

60.7

429

1822

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.9

60.6

181

472

A11

ICPC

Chest pain NOS

1.8

60.5

886

4944

N02BF02

ATC

pregabalin; oral

2.0

60.3

722

3772

N05BA02

ATC

chlordiazepoxide; systemic

2.9

60.1

289

1014

S22.3

ICD-10 Finland

Fracture of rib

1.9

60.1

784

4216

R03AC13

ATC

formoterol; inhalant

2.1

60.0

579

2797

K04.0

ICD-10 Finland

Pulpitis

1.6

59.9

1351

8513

F61.0

ICD-10 Finland

Mixed personality disorders

2.8

59.8

295

1050

L02

ICPC

Back symptom/complaint

1.6

59.8

1364

8620

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

59.5

852

4720

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

59.5

795

4308

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

59.4

1167

7092

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

59.3

1749

11749

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

59.2

5003

40750

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

59.2

1652

10957

SPAT1301

SPAT

No procedures

1.4

59.2

3712

28834

P06

ICPC

Sleep disturbance

1.6

59.0

1576

10347

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

58.8

1439

9250

P18

ICPC

Medication abuse

4.5

58.7

143

320

SPAT1307

SPAT

Psychosocial counselling and guidance

1.7

58.6

1076

6416

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

58.6

944

5422

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

4.7

58.5

136

293

B01AB05

ATC

enoxaparin; parenteral

1.4

58.5

3299

25163

SFA30

NOMESCO Finland

Three-surface restoration

1.3

58.2

5034

41117

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

58.2

3844

30102

L16

ICPC

Ankle symptom/complaint

1.6

58.1

1481

9615

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

6.2

58.0

158

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.8

57.9

875

4928

W64

ICD-10 Finland

Exposure to other and unspecified animate mechanical forces

4.3

57.7

149

349

P99

ICPC

Psychological disorders other

2.3

57.6

465

2092

D06

ICPC

Abdominal pain localized other

1.7

57.4

1166

7145

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

57.3

857

4811

T67.1

ICD-10 Finland

Heat syncope

150.6

56.9

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.1

56.5

540

2599

S21

ICPC

Skin texture symptom/complaint

1.6

56.4

1629

10881

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.2

56.3

463

2099

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

56.2

3235

24729

A28

ICPC

Limited function/disability NOS

1.6

56.2

1432

9291

N06AB05

ATC

paroxetine; oral

1.9

56.2

768

4191

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.7

56.1

312

1182

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

56.0

1088

6586

K08.80

ICD-10 Finland

Toothache NOS

1.7

56.0

1191

7385

N05BE01

ATC

buspirone; oral

2.4

55.8

393

1666

SPAT1265

SPAT

Breathalyser

3.8

55.8

172

459

SFA20

NOMESCO Finland

Two-surface restoration

1.3

55.7

7775

67887

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

55.7

1282

8113

W99

ICD-10 Finland

Exposure to other and unspecified man-made environmental factors

6.2

55.5

155

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

55.4

767

4202

F41.00

ICD-10 Finland

Moderate panic disorder

2.7

55.3

296

1100

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

55.2

3367

25977

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

55.2

2107

14929

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

5.7

55.2

103

183

M54.2

ICD-10 Finland

Cervicalgia

1.7

55.0

986

5839

SPAT1227

SPAT

Substance abuse rehabilitation

4.4

54.8

136

309

R03BA08

ATC

ciclesonide; inhalant

1.7

54.7

1059

6403

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.2

54.7

453

2059

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

54.3

3239

24888

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

54.2

2406

17546

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.1

53.8

526

2553

R07.0

ICD-10 Finland

Pain in throat

1.7

53.7

1036

6259

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

5.4

53.6

105

195

Z72.1

ICD-10 Finland

Alcohol use

3.3

53.6

202

615

S20.2

ICD-10 Finland

Contusion of thorax

2.0

53.5

626

3242

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

53.4

1997

14081

K92.0

ICD-10 Finland

Haematemesis

2.8

53.4

280

1029

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

53.4

1497

9925

R03AC12

ATC

salmeterol; inhalant

2.2

53.4

485

2288

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.3

53.3

422

1882

S00.0

ICD-10 Finland

Superficial injury of scalp

2.7

53.3

290

1087

SGA01

NOMESCO Finland

Emergency treatment

1.5

53.3

2190

15735

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

52.7

740

4072

SFA10

NOMESCO Finland

One-surface restoration

1.3

52.7

7337

63816

WZC30

NOMESCO Finland

Teaching

1.5

52.7

1685

11501

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

52.7

895

5217

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.1

52.6

526

2575

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.2

52.3

139

333

B02AA02

ATC

tranexamic acid; systemic

1.5

52.3

1788

12377

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

52.3

3220

24848

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.0

52.1

575

2918

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

2.8

51.9

271

994

T75.2

ICD-10 Finland

Effects of vibration

138.0

51.8

A99

ICPC

Disease/condition unspecnature/site

1.7

51.5

1045

6396

J01DA09

ATC

[U] cefadroxil

1.4

51.5

3210

24809

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

51.4

1330

8651

R29

ICPC

Respiratory symptom/complaint other

1.8

51.3

842

4857

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

51.2

573

2922

N06AX26

ATC

vortioxetine; oral

1.7

51.1

1039

6362

N06AX03

ATC

mianserin; oral

2.1

51.1

517

2542

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

51.0

698

3808

F29

ICPC

Eye symptom/complaint other

1.6

51.0

1165

7350

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.3

50.9

389

1710

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

50.9

740

4117

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

50.5

821

4724

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

50.4

1136

7144

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

50.3

549

2774

T70.3

ICD-10 Finland

Caisson disease [decompression sickness]

+∞

50.0

UKC02

NOMESCO Finland

Cystoscopy

1.6

50.0

1402

9288

SPAT1312

SPAT

General health counselling

1.3

50.0

4113

33154

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

49.7

2987

22925

R06AX26

ATC

fexofenadine; oral

1.7

49.7

902

5355

SPAT1272

SPAT

Drug screening

5.1

49.6

105

209

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

49.6

682

3726

U02

ICPC

Urinary frequency/urgency

1.5

49.5

1612

11034

L08

ICPC

Shoulder symptom/complaint

1.4

49.5

2375

17535

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.9

49.3

144

370

W10

ICD-10 Finland

Fall on and from stairs and steps

1.9

49.3

606

3192

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.8

49.2

243

866

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

49.1

983

5995

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

4.5

49.0

119

266

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

48.8

1056

6570

N06AX05

ATC

trazodone; oral

2.4

48.8

348

1484

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

8.2

48.7

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.8

48.7

723

4048

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.0

48.6

140

356

R05

ICD-10 Finland

Cough

1.4

48.6

2486

18557

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

5.1

48.6

101

198

X99.9

ICD-10 Finland

Assault by sharp object by unknown person

8.1

48.5

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

48.5

944

5712

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

48.5

933

5628

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

683

311

23.03

307.65

1.3

1.2

0.31

0.30

g/l

1.42

529

253

(3005322) IgE [Units/volume] in Serum or Plasma

2061

7964

2.86

307.65

1.5

1.3

375.79

222.50

u/ml

4.73

1976

7348

(3019420) Tryptase [Mass/volume] in Serum or Plasma

766

507

15.92

307.65

1.5

1.6

7.68

7.32

ug/l

0.17

660

467

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1214

3453

3.75

307.65

1.7

1.8

0.23

g/l

0.95

1110

3305

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1218

3568

3.64

307.65

1.7

1.8

1.19

1.17

g/l

1.45

1121

3420

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

335

233

14.70

307.65

1.2

1.1

11.00

7.29

u/ml

0.41

249

169

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

327

105

31.86

307.65

1.0

0.46

0.25

u/ml

0.32

194

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

664

275

25.29

307.65

1.3

1.2

111.97

110.23

0.47

609

240

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4811

29173

1.99

294.89

2.6

2.1

237.23

208.06

u/l

0.81

4584

27469

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7586

53896

1.88

283.72

6.2

5.9

10.48

11.09

umol/l

3.54

7192

50969

(3013826) Glucose [Moles/volume] in Serum or Plasma

8407

61977

1.88

277.12

5.8

4.5

6.54

mmol/l

0.03

7969

57024

(3022096) Basophils/100 leukocytes in Blood

7290

51604

1.85

271.02

6.7

6.2

0.65

0.68

4.14

6868

48323

(3013115) Eosinophils [#/volume] in Blood

8062

58948

1.86

269.40

6.9

6.3

0.20

0.19

e9/l

8.45

7199

52218

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

212

114

18.86

268.78

1.0

0.30

0.08

u/ml

1.31

124

(3006315) Basophils [#/volume] in Blood

7842

56903

1.85

267.97

6.6

6.0

0.04

e9/l

1.17

6891

49691

(3001604) Monocytes [#/volume] in Blood

7825

56792

1.85

266.66

6.6

6.0

0.57

0.56

e9/l

2.84

6871

49656

(3006504) Eosinophils/100 leukocytes in Blood

7464

53397

1.84

266.42

6.7

6.2

2.91

2.83

2.32

7045

50180

(3019069) Monocytes/100 leukocytes in Blood

7496

53713

1.84

265.99

6.9

6.4

8.20

8.36

4.58

7091

50563

(3013650) Neutrophils [#/volume] in Blood by Automated count

8683

65284

1.86

261.94

9.5

9.0

4.24

4.01

e9/l

14.28

7661

57207

(3002030) Lymphocytes/100 leukocytes in Blood

7676

55777

1.83

256.42

6.7

6.2

28.57

29.08

3.98

7287

52667

(40760892) CBC W Ordered Manual Differential panel - Blood

7424

53540

1.82

252.89

7.0

6.5

—

(3019198) Lymphocytes [#/volume] in Blood

7989

58939

1.82

251.93

6.6

6.0

2.00

1.96

e9/l

1.23

7207

52694

(3018010) Neutrophils/100 leukocytes in Blood

7569

54942

1.81

251.92

6.5

6.0

56.79

56.45

1.78

7174

51843

(3022217) INR in Platelet poor plasma by Coagulation assay

6338

43637

1.82

251.32

12.3

11.8

1.14

1.19

inr

6.02

2205

13354

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10307

82737

1.91

242.49

8.3

7.1

76.37

76.50

u/l

0.10

9826

78147

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

201

121

16.84

241.36

1.1

1.0

5.14

0.50

u/ml

0.96

116

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

210

138

15.43

241.01

1.1

4.28

2.28

u/ml

0.67

162

109

(3023368) Bacteria identified in Blood by Culture

4155

25367

1.90

239.35

4.7

4.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

195

116

17.03

235.53

1.1

1.0

0.73

0.15

u/ml

1.20

113

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

186

101

18.65

234.68

1.1

1.0

0.88

0.11

u/ml

1.94

108

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5385

36077

1.80

227.23

4.1

3.1

70.25

58.83

ng/l

0.11

3204

21043

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6875

49463

1.76

226.59

7.5

6.6

1.21

mmol/l

2.12

5939

42167

(3011841) English Walnut IgE Ab [Units/volume] in Serum

200

139

14.58

222.62

1.1

6.59

4.00

u/ml

0.37

155

108

(3012494) Peanut IgE Ab [Units/volume] in Serum

316

430

7.49

218.71

1.1

15.68

9.95

u/ml

0.25

233

244

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5003

33110

1.79

217.68

3.1

2.5

54.32

61.40

u/l

2.20

4637

30690

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6303

44645

1.74

215.96

6.9

6.0

1.21

mmol/l

3.58

5823

41021

(3002582) Erythrocytes [#/volume] in Urine

4781

31397

1.79

212.30

3.6

3.1

61.44

76.34

e6/l

0.32

3807

23717

(3013707) Erythrocyte sedimentation rate by Westergren method

10139

82646

1.81

205.99

4.6

3.8

11.24

10.55

mm/h

5.90

9507

77107

(3021589) Normoblasts [#/volume] in Blood

6856

50588

1.69

195.32

10.6

8.9

0.00

e9/l

2.92

5674

41420

(3018095) Leukocytes [#/volume] in Urine

5447

37857

1.71

193.42

4.3

3.5

81.86

84.59

e6/l

0.06

4008

25772

(3030467) Casts [#/volume] in Urine by Automated count

4365

28704

1.75

187.84

3.6

3.0

0.34

0.37

e6/l

0.50

3414

21445

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3868

24660

1.78

184.74

2.0

1.8

0.99

1.11

mg/l

1.17

2833

18329

(36304419) Bacteria [Presence] in Urine

4311

28409

1.75

183.18

3.5

2.9

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

151

16.58

180.12

1.0

1.00

2.33

u/ml

0.51

(3037467) Urinalysis macro (dipstick) panel - Urine

9543

77805

1.70

178.13

5.0

4.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2676

15398

1.91

176.93

2.0

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

9138

73822

1.68

174.84

5.4

4.1

1245.63

1442.82

e6/l

0.14

142

918

(3019550) Sodium [Moles/volume] in Serum or Plasma

12783

114351

2.26

173.18

19.1

13.1

139.47

139.62

mmol/l

11.04

12571

111374

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

135

18.66

170.55

1.0

2.21

1.94

u/ml

0.05

105

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3017

18232

1.83

170.14

4.0

3.4

204.08

497.08

ng/l

4.33

1945

12557

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12963

116799

2.36

169.67

18.3

12.0

20.38

21.85

mg/l

6.16

10985

90329

(3000850) Epithelial cells [#/volume] in Urine

3437

21627

1.78

169.19

2.9

2.5

7.03

6.30

e6/l

1.98

3129

19321

(3023103) Potassium [Moles/volume] in Serum or Plasma

12793

114714

2.24

168.27

19.2

13.2

3.93

3.94

mmol/l

9.11

12561

111456

(3026782) Osmolality of Urine

3272

20374

1.79

166.53

3.1

2.7

529.73

544.21

mosm/kgh2o

2.77

2874

17450

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5284

37514

1.65

165.99

3.4

3.2

34.43

32.87

u/l

0.39

4990

35663

(40758558) Short blood count panel - Blood

4169

27951

1.70

162.33

6.8

6.9

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

5942

43712

1.62

160.10

5.1

4.9

36.00

36.23

g/l

2.57

5563

40751

(3028707) Methadone [Presence] in Urine by Screen method

840

3124

2.80

157.68

4.3

2.6

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

118

20.51

155.50

1.0

0.85

0.22

u/ml

1.19

109

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

137

14.55

152.59

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

128

16.14

150.67

1.1

0.82

1.06

u/ml

0.23

(3033658) Prothrombin time (PT) actual/Normal

4022

27147

1.67

150.38

4.4

4.0

93.59

92.68

1.54

3917

26423

(3027231) Wheat IgE Ab [Units/volume] in Serum

216

293

7.47

149.83

1.1

9.31

1.87

u/ml

0.80

174

257

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5442

39913

1.59

143.77

2.1

1.9

95.67

97.30

pmol/l

1.78

3014

21208

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

11952

105944

1.84

142.72

15.4

10.8

89.58

88.04

ml/min/173m2

11.17

10295

86443

(3018418) pH of Serum or Plasma

4204

29052

1.64

141.58

4.3

4.0

7.40

0.38

879

5643

(3026008) Bacteria identified in Urine by Culture

4453

31220

1.62

141.42

3.3

2.8

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

117

16.61

139.78

1.0

17.90

22.89

u/ml

0.26

(3012544) pH of Venous blood

1689

9101

1.97

132.52

4.5

7.36

7.37

0.08

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1644

8815

1.98

130.73

4.6

4.5

5.85

5.83

kpa

0.33

1588

8557

(3002032) Base excess in Venous blood by calculation

1636

8769

1.98

130.20

4.6

1.71

1.79

mmol/l

0.38

1386

7371

(3014111) Lactate [Moles/volume] in Serum or Plasma

1557

8237

2.00

128.55

7.4

7.5

1.41

1.34

mmol/l

1.59

1524

8032

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2646

16556

1.74

127.93

2.4

1.7

1.54

1.39

18.06

2307

14832

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1841

10335

1.90

127.50

1.9

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10486

90730

1.61

124.58

4.6

4.0

14.50

14.57

pmol/l

2.18

9738

83567

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

117

13.25

123.57

1.4

12.44

3.54

u/ml

0.88

103

(3037522) Nuclear Ab [Titer] in Serum

2605

16384

1.72

123.08

1.4

536.55

540.18

titre

0.03

498

3262

(3020191) Ethanol [Moles/volume] in Serum or Plasma

375

993

3.85

122.71

1.9

1.4

1.63

1.32

promille

3.06

274

749

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1836

10427

1.87

122.30

1.9

1.7

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

114

13.51

121.81

1.1

1.0

7.70

7.90

u/ml

0.03

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

24.85

119.48

1.0

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9512

80810

1.54

119.18

4.0

2.9

47.98

41.92

u/l

8.05

9000

76476

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1766

10020

1.87

117.68

2.6

2.5

72.87

42.84

u/l

0.34

1499

8599

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2416

15084

1.73

116.53

2.2

2.4

29.84

29.69

0.58

2344

14612

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2530

16013

1.71

116.03

3.8

3.7

0.82

mmol/l

1.26

2382

15084

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

11866

106524

1.72

115.33

5.5

4.6

1.97

2.04

mu/l

0.16

11166

99381

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2549

16298

1.69

112.13

3.1

2.8

4.13

3.03

e6/l

3.57

1380

8589

(3007853) Bacteria identified in Skin by Aerobe culture

2112

12910

1.75

109.18

1.9

1.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

4605

34073

1.52

108.62

3.1

3.2

2.35

mmol/l

2.30

4106

30383

(3024354) Oxygen [Partial pressure] in Venous blood

1355

7276

1.95

106.12

4.1

4.0

4.73

kpa

0.02

1301

7043

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

741

3145

2.43

105.43

2.4

631.05

514.98

ug/l

0.40

685

2906

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2005

12219

1.75

104.36

2.7

2.9

7.14

7.51

umol/l

0.30

1684

10513

(3021960) Folate [Moles/volume] in Serum or Plasma

3174

21846

1.58

102.61

1.6

1.5

19.56

20.37

nmol/l

2.52

2761

19004

(3013512) EKG study

3791

27185

1.54

102.08

3.9

3.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

280

687

4.14

101.80

1.2

1.1

—

(3000991) Gas panel - Venous blood

1466

8222

1.87

100.35

9.3

9.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

6898

55926

1.46

100.32

5.5

4.5

0.00

estimate

0.15

1579

10911

(3011288) Drugs identified in Urine by Screen method

1030

5115

2.09

100.14

5.3

2.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

685

2874

2.45

99.87

1.1

5.03

6.31

u/ml

1.33

468

1560

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

312

841

3.77

99.50

1.2

1.3

4.01

1.87

u/ml

2.26

232

453

(3009261) Glucose [Presence] in Urine by Test strip

6939

56396

1.45

99.16

4.1

3.4

0.00

estimate

0.18

1537

10634

(3035350) Ketones [Presence] in Urine by Test strip

6888

55915

1.45

98.98

4.1

3.3

0.00

estimate

0.41

1631

11266

(3007164) IgA [Mass/volume] in Serum or Plasma

3525

25091

1.54

97.34

1.5

1.4

2.29

2.26

g/l

0.54

2110

15836

(3036180) Methadone [Presence] in Urine

301

804

3.80

97.26

2.6

2.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1131

5884

2.00

96.68

3.8

2.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

13.31

95.40

1.1

1.0

1.69

0.93

u/ml

0.45

(3044640) Blood type and Crossmatch panel - Blood

4585

34598

1.48

95.19

2.5

2.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2505

16552

1.62

95.10

1.8

1.7

1127.65

1174.95

nmol/l

1.80

1926

12733

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2605

17402

1.61

94.48

3.0

2.6

1.31

1.27

e6/l

0.05

1444

9659

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

11.34

93.98

1.1

1.0

—

(40768797) Stomach Pathology biopsy report

2201

14156

1.66

92.82

1.3

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3286

23250

1.54

92.47

3.0

2.9

1163.80

1190.53

ng/l

0.13

2736

19493

(3042936) Bacteria identified in Isolate by Culture

2232

14477

1.64

90.87

2.1

2.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3933

29007

1.49

90.49

1.4

1.3

1.65

1.69

u/ml

0.06

1053

8066

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3931

29003

1.49

90.23

1.9

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

640

2731

2.41

89.78

1.1

3.02

2.12

u/ml

1.18

436

1407

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3641

26504

1.50

89.03

2.5

2.2

2.76

2.82

mg/l

0.72

3138

22818

(3022948) Iron [Moles/volume] in Serum or Plasma

2413

16048

1.61

88.49

2.6

2.4

12.99

13.77

umol/l

5.77

2231

15073

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1751

10729

1.72

88.26

2.3

2.2

362.53

374.30

nmol/l

1.13

1624

9881

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

712

3215

2.28

87.67

1.2

1.1

2.61

2.28

u/ml

0.35

476

1649

(3015736) pH of Urine

5708

45512

1.43

86.00

3.7

3.1

5.95

5.92

0.38

483

4289

(3008401) Mugwort IgE Ab [Units/volume] in Serum

632

2747

2.36

85.00

1.1

1.29

1.19

u/ml

0.14

407

1216

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2884

20174

1.54

84.35

1.4

1.3

25.69

30.64

iu/ml

1.06

809

6380

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2221

14671

1.61

83.26

2.6

2.4

2.40

2.39

g/l

0.34

2021

13669

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2742

19047

1.55

82.56

1.3

9.12

10.80

u/ml

0.69

979

7823

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5716

45847

1.41

82.03

2.6

2.3

72.98

2021.26

nmol/l

0.50

5233

42133

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1252

7111

1.83

81.51

1.6

1.7

—

(3016879) Cocaine [Presence] in Urine

1247

7078

1.84

81.35

3.7

2.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

960

5044

1.97

79.28

4.7

5.1

24.16

24.04

mmol/l

0.52

936

4958

(3016502) Oxygen saturation in Arterial blood

1495

9033

1.73

78.70

8.6

8.0

95.33

95.92

2.34

1452

8669

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1155

6468

1.86

78.58

8.5

8.2

24.75

24.68

mmol/l

0.27

1144

6428

(3003396) Base excess in Arterial blood by calculation

1646

10217

1.69

78.49

8.3

7.5

0.86

0.91

mmol/l

0.18

1318

8003

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2061

13555

1.61

78.21

2.7

2.5

22.20

23.42

3.42

1784

11718

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3159

22906

1.49

76.78

2.6

2.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2912

20774

1.51

76.63

2.5

2.1

—

(3028300) Cannabinoids [Presence] in Urine

1311

7688

1.78

76.52

3.7

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

1302

7620

1.78

76.52

3.7

2.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6595

54656

1.39

76.01

3.3

2.9

104.85

101.66

ug/l

0.49

6145

51386

(3027008) Opiates [Presence] in Urine

1302

7673

1.77

74.63

3.7

1.9

—

(3009343) pH of Capillary blood

1110

6259

1.84

73.70

4.5

4.1

7.41

0.49

177

737

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1120

6333

1.83

73.69

4.6

4.1

5.16

5.12

kpa

0.95

1079

6029

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1392

8397

1.73

73.44

8.9

8.4

123.84

122.03

g/l

2.54

1365

8150

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

980

5320

1.90

73.29

1.7

1.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1623

10211

1.67

73.19

8.3

7.5

12.25

12.95

kpa

5.74

1562

9730

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1623

10217

1.67

73.02

8.3

7.5

5.10

5.08

kpa

0.31

1563

9737

(3044889) 12 lead EKG panel

8457

73270

1.39

72.97

3.7

3.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1045

5821

1.86

72.09

1.6

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

800

4080

2.02

71.75

1.6

1.3

—

(3027944) Amphetamines [Presence] in Urine

1276

7564

1.76

71.53

3.5

1.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1076

6065

1.84

71.45

4.5

4.1

1.74

1.50

mmol/l

1.39

779

4405

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6405

53178

1.37

71.21

2.8

2.5

—

(3048689) Calprotectin [Mass/mass] in Stool

2366

16385

1.53

70.96

2.5

114.22

123.97

ug/g

0.73

1858

12961

(3002385) Erythrocyte distribution width [Ratio]

11266

102830

1.47

70.75

20.5

14.4

14.59

14.70

0.50

11163

101036

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1943

12915

1.59

69.84

6.6

6.3

1.06

mmol/l

0.28

1846

12103

(3015076) Soybean IgE Ab [Units/volume] in Serum

276

880

3.18

67.84

1.1

1.0

1.76

0.93

u/ml

0.38

158

227

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13011

122946

1.75

67.45

12.1

9.3

27.60

26.68

u/l

4.31

12726

119103

(3020874) Milk IgE Ab [Units/volume] in Serum

296

999

3.01

66.00

1.3

1.1

9.70

1.77

u/ml

1.81

193

346

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3474

26276

1.43

65.95

2.5

2.2

—

(3009508) Creatinine [Moles/volume] in Urine

4011

31133

1.40

65.63

3.8

3.2

7.71

7.93

mmol/l

1.87

3409

26940

(3004119) Hemoglobin [Mass/volume] in Venous blood

953

5404

1.82

61.80

3.8

131.38

130.37

g/l

0.72

935

5280

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1283

7920

1.68

61.66

2.8

2.3

8808.55

5834.83

u/l

1.66

480

3154

(3000492) Spirometry study

1767

11805

1.57

61.52

1.5

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1564

10157

1.61

61.45

2.6

2.8

1.77

1.74

0.47

1381

9068

(3015235) Bicarbonate [Moles/volume] in Capillary blood

510

2323

2.24

61.29

3.6

3.4

24.63

24.49

mmol/l

0.33

501

2277

(3014599) Egg white IgE Ab [Units/volume] in Serum

285

985

2.93

60.93

1.2

1.1

14.11

2.49

u/ml

1.25

168

257

(3026493) Urate [Moles/volume] in Serum or Plasma

3479

26628

1.41

60.85

2.6

2.5

2894.44

3505.27

umol/l

0.52

3042

23776

(4200892) Spirometry reversibility

1189

7226

1.70

60.53

1.5

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

462

2033

2.32

60.26

3.0

2.4

16.58

16.64

0.12

239

1011

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

9978

89951

1.37

60.22

4.0

3.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2413

17308

1.48

59.93

1.8

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1374

8716

1.64

59.28

2.5

2.6

10.37

10.44

g/l

0.26

1253

8008

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1619

10693

1.58

59.08

3.6

4.4

228.19

238.96

u/l

2.96

1525

10130

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10820

98968

1.40

58.89

5.6

4.9

39.04

38.66

mmol/mol

3.75

10140

92853

(3042517) Benzodiazepines panel - Urine

107

189

5.70

57.65

3.5

2.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11549

106966

1.44

57.59

4.5

3.9

5.87

5.78

mmol/l

10.36

10667

99163

(40761511) CBC panel - Blood by Automated count

12921

122598

1.64

56.54

15.9

11.1

—

(3021901) Oxygen saturation in Capillary blood

392

1655

2.41

56.18

3.2

3.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1318

8438

1.62

54.58

8.0

8.1

8.59

8.77

mmol/l

0.43

1268

8081

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

953

5625

1.74

53.71

10.4

9.6

0.64

0.68

2.29

947

5589

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

184

528

3.52

53.59

3.0

2.0

194.45

144.92

umol/l

0.92

258

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1501

9959

1.57

53.37

3.9

3.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

901

5247

1.77

53.21

2.1

1.8

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

952

5636

1.74

53.07

10.2

9.5

1.41

1.38

0.41

946

5599

(3041096) Erythrocytes [Presence] in Urine by Automated

3973

31660

1.35

52.73

3.7

2.9

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2376

17376

1.44

52.54

2.8

2.9

2.44

mmol/l

0.08

2066

15138

(1616796) Gas panel - Central venous blood

466

2181

2.18

52.35

4.0

3.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

447

2061

2.21

52.12

2.4

3.0

33.00

34.68

umol/l

0.88

413

1896

(3028271) Lactate [Moles/volume] in Capillary blood

365

1546

2.40

51.95

2.2

1.8

1.73

1.71

mmol/l

0.14

357

1513

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

20.58

51.31

1.0

0.14

0.02

u/ml

—

(3027315) Oxygen [Partial pressure] in Blood

474

2260

2.14

50.78

4.2

3.9

8.88

8.82

kpa

0.26

463

2218

(3012501) Base excess in Blood by calculation

471

2245

2.14

50.50

4.2

3.9

2.17

2.34

mmol/l

0.75

304

1482

(3013290) Carbon dioxide [Partial pressure] in Blood

471

2246

2.13

50.44

4.2

3.9

5.01

kpa

0.07

460

2205

(3010421) pH of Blood

523

2599

2.05

50.21

4.3

3.9

7.42

0.13

478

2376

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5228

43609

1.32

50.00

4.2

3.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

692

3799

1.86

49.60

5.0

3.9

51.49

49.32

1.46

683

3753

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1137

7190

1.63

49.29

2.6

2.3

5.24

7.37

ug/l

4.78

990

6274

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1417

9448

1.56

49.08

2.3

2.4

0.22

g/l

0.15

1306

8839

(3028026) IgM [Mass/volume] in Serum or Plasma

1076

6734

1.65

48.59

1.9

1.8

1.43

1.30

g/l

0.98

992

6215

(44816559) Phosphatidylethanol [Mass/volume] in Blood

508

2534

2.04

48.26

1.6

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

821

4786

1.76

48.22

10.6

9.9

24.17

24.19

mmol/l

0.06

801

4644

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

843

4965

1.74

47.75

10.1

10.2

—

(3017181) Myelocytes/100 leukocytes in Blood

1350

8957

1.56

47.73

4.3

0.78

0.91

0.99

451

2836

(46235355) HIV 1 and 2 tests - Meaningful Use set

3927

31677

1.33

46.83

2.2

2.0

—

(3000494) Fungus identified in Specimen by Culture

1790

12653

1.47

46.81

1.5

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

15.23

46.79

1.0

0.35

1.30

u/ml

0.50

(3021440) Promyelocytes/100 leukocytes in Blood

1295

8550

1.57

46.74

4.3

0.09

0.12

0.50

394

2440

(3027273) Bicarbonate [Moles/volume] in Venous blood

727

4129

1.80

46.64

4.3

3.5

25.06

25.17

mmol/l

0.40

704

3993

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2730

20837

1.38

46.56

1.7

1.6

17960329.40

30007762.19

pmol/l

0.77

2294

17729

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1218

7942

1.58

46.39

4.0

3.7

1.22

1.23

mmol/l

2.73

1064

6983

(3028626) Oxygen [Partial pressure] in Capillary blood

525

2688

1.99

46.36

5.5

4.8

8.52

8.77

kpa

2.73

508

2619

(3052851) Hemolysis interference index of Serum or Plasma

588

3131

1.92

46.29

2.8

2.9

—

(3022145) Colonoscopy Study observation

1694

11883

1.48

45.98

1.3

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1243

8160

1.57

45.96

2.4

2.3

19.10

22.67

au/ml

0.73

721

(3011397) Hemoglobin [Presence] in Urine by Test strip

3258

25677

1.35

45.14

3.8

3.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

801

4731

1.73

44.87

1.3

2.17

0.97

u/ml

0.88

405

(3023520) Reticulocytes [#/volume] in Blood

1136

7357

1.59

44.47

2.6

2.7

70.79

70.37

e9/l

0.14

817

5440

(3002179) Metamyelocytes/100 leukocytes in Blood

1241

8228

1.56

43.85

4.0

4.1

0.48

0.65

2.83

402

2472

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1152

7523

1.58

43.49

1.3

41.89

50.33

au/ml

0.56

377

(3025159) Blasts/100 leukocytes in Blood

1233

8183

1.56

43.35

4.3

4.4

0.02

0.35

2.99

331

2077

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1388

9481

1.51

42.71

1.3

1.2

132.65

146.50

iu/ml

0.47

484

3671

(3029937) Albumin [Presence] in Urine by Test strip

3683

29750

1.32

42.67

4.5

3.7

0.00

estimate

1.87

1533

10560

(40768804) Tissue Pathology biopsy report

5290

44952

1.28

41.56

2.1

2.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

458

2328

2.00

41.29

1.1

6.38

4.59

u/ml

1.07

288

1151

(3000570) Elastase.pancreatic [Mass/mass] in Stool

546

2952

1.88

41.00

1.5

1.4

292.75

282.83

ug/g

0.48

286

1646

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

163

5.18

40.94

1.0

—

(3025941) Bacteria identified in Stool by Culture

1075

7005

1.58

40.88

1.3

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

13578

131662

1.84

40.76

26.0

17.7

40.25

40.69

3.91

13086

124699

(3022806) Fractional oxyhemoglobin in Capillary blood

298

1287

2.34

40.65

2.0

1.8

90.42

90.28

0.16

293

1271

(3009466) Valproate [Moles/volume] in Serum or Plasma

353

1646

2.17

40.06

5.7

5.3

358.96

372.61

umol/l

0.91

305

1433

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

13.74

39.89

1.1

1.0

—

(3007461) Platelets [#/volume] in Blood

13583

131792

1.83

39.72

25.9

17.6

260.62

257.14

e9/l

8.33

13389

128734

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

499

2652

1.91

39.49

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1125

7477

1.55

39.16

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

428

2167

2.01

39.02

1.1

6.32

5.65

u/ml

0.29

251

934

(3020630) Protein [Mass/volume] in Serum or Plasma

1085

7165

1.56

38.86

2.4

2.5

66.64

66.70

g/l

0.09

1007

6597

(3035941) MCH [Entitic mass]

13586

131907

1.81

38.53

25.7

17.5

30.15

30.13

0.87

13503

130336

(3024928) Oxygen saturation in Venous blood

403

2006

2.04

38.52

2.9

4.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

420

2123

2.01

38.47

1.4

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

236

940

2.54

38.44

2.1

2.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

420

2124

2.01

38.42

1.4

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

13587

131937

1.81

38.26

25.8

17.6

4.51

4.54

e12/l

7.66

13363

128600

(3024731) MCV [Entitic volume]

13585

131917

1.81

38.18

25.7

17.5

90.43

90.26

4.41

13503

130343

(3010813) Leukocytes [#/volume] in Blood

13587

131960

1.81

37.90

25.9

17.6

7.01

6.69

e9/l

44.03

13358

128570

(3000963) Hemoglobin [Mass/volume] in Blood

13588

131986

1.80

37.70

26.0

17.7

135.21

136.07

g/l

10.72

13503

130420

(3048929) Epstein Barr virus Ab [Presence] in Serum

817

5081

1.65

37.60

1.4

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

176

611

2.90

37.47

2.1

1.7

1039034.44

1963692.77

iu/ml

0.60

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

378

1885

2.03

35.97

1.1

0.71

0.40

u/ml

0.56

173

516

(40761536) Microorganisms panel - Urine sediment

1398

9945

1.45

34.73

4.5

3.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

881

5695

1.58

34.54

2.1

2.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

855

5491

1.59

34.46

7.6

6.9

24.31

24.45

mmol/l

0.51

820

5198

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

452

2437

1.88

34.25

2.0

2.1

0.01

0.03

g/l

1.13

424

2241

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3175

25779

1.30

34.00

1.8

1.7

—

(36660697) Celiac disease serology panel - Serum

1450

10437

1.43

33.76

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

422

2238

1.91

33.64

2.0

2.1

0.00

g/l

0.27

395

2050

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

616

3662

1.71

33.62

1.9

—

(3019060) Gas panel - Arterial blood

874

5675

1.58

33.59

5.1

4.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

508

2859

1.81

33.55

1.8

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

417

2208

1.92

33.40

2.0

2.1

0.00

g/l

-0.00

396

2046

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1520

11063

1.42

33.24

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

487

2714

1.82

33.22

2.0

2.2

0.73

0.78

g/l

0.11

440

2369

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

527

3011

1.78

33.08

1.3

11.30

8.78

u/ml

0.28

482

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

35.10

32.71

1.0

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

451

2468

1.85

32.63

2.0

2.1

38.38

38.20

g/l

0.25

413

2190

(3003327) Ova and parasites identified in Stool by Light microscopy

720

4500

1.63

32.43

1.7

—

(3019225) pH of Specimen

1309

9322

1.45

32.22

4.2

4.0

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

713

4458

1.63

32.07

1.4

1.6

7.75

11.88

u/ml

—

144

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

516

2961

1.77

31.91

1.3

4.36

7.28

u/ml

0.65

305

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1801

13577

1.37

31.90

2.1

2.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

548

3201

1.74

31.86

2.0

2.2

7.25

7.35

g/l

0.65

510

2925

(3017958) Strawberry IgE Ab [Units/volume] in Serum

10.02

31.78

1.0

0.27

0.06

u/ml

0.55

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

558

3280

1.73

31.72

1.3

32.16

37.32

u/ml

0.19

223

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

524

3029

1.76

31.60

2.0

2.2

2.91

g/l

0.03

486

2755

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

546

3197

1.74

31.47

2.0

2.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

793

5113

1.58

31.39

2.9

2.6

0.24

0.25

e6/l

0.12

764

4952

(3007456) Orange IgE Ab [Units/volume] in Serum

10.65

31.29

1.0

0.05

0.09

u/ml

0.31

(3021387) Prolactin [Units/volume] in Serum or Plasma

920

6140

1.53

31.24

1.7

1.6

340.69

313.76

mu/l

1.13

825

5526

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

545

3197

1.73

31.21

2.0

2.2

3.76

3.64

g/l

0.96

506

2923

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

561

3326

1.72

30.92

2.2

1.9

1.73

2.27

ug/l

0.72

494

2933

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

142

488

2.93

30.88

1.0

15.64

11.82

u/ml

0.70

297

(3007463) Buprenorphine [Presence] in Urine

6.93

30.88

10.0

5.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

514

2975

1.76

30.86

2.0

2.2

10.18

10.17

g/l

0.03

475

2679

(3022313) Gas panel - Capillary blood

729

4632

1.61

30.69

4.9

4.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

280

1328

2.13

30.51

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3355

27751

1.27

30.47

4.1

3.9

16.44

10.03

mg/mmol

0.65

2150

17922

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

514

2987

1.75

30.43

1.3

1.5

481.15

490.83

mg/l

0.08

495

2846

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

700

4432

1.61

29.90

1.6

1.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

586

3555

1.68

29.65

1.5

1.6

199.42

308.37

titre

0.82

153

(3019150) Specific gravity of Urine by Refractometry

2974

24400

1.28

28.56

4.3

3.6

1.02

kg/l

0.10

428

3610

(3000330) Specific gravity of Urine by Test strip

735

4764

1.57

28.41

3.3

3.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

589

3618

1.66

28.40

5.3

5.1

1.92

1.71

2.72

559

3368

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

298

1490

2.02

28.23

1.2

0.52

1.62

nmol/l

0.76

284

1442

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

299

1498

2.02

28.16

1.2

0.27

0.24

nmol/l

0.11

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1012

7049

1.47

27.85

3.0

2.9

155.61

169.44

ng/l

0.57

896

6315

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

457

2638

1.76

27.71

1.2

1.4

3.69

3.67

mmol/l

0.18

431

2484

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1451

10801

1.38

27.54

2.0

1.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

717

4664

1.57

27.28

1.9

2.0

39.71

39.48

u/l

0.12

664

4222

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

482

2838

1.72

27.25

1.3

1.4

19.42

11.37

iu/ml

0.50

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1098

7802

1.44

27.19

3.1

3.4

4.52

4.55

pmol/l

0.44

980

7008

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

194

833

2.35

26.96

1.8

1.5

—

(3012516) Albumin [Mass/volume] in Urine

3184

26492

1.26

26.96

3.5

3.3

313.06

440.32

mg/l

0.97

2119

17151

(3007930) Methemoglobin/Hemoglobin.total in Blood

577

3575

1.64

26.90

5.3

5.2

0.87

0.91

1.25

547

3334

(3044290) Cell count panel - Cerebral spinal fluid

433

2489

1.76

26.65

1.2

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

413

2345

1.78

26.52

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

523

3173

1.67

26.47

1.2

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

388

2180

1.80

25.82

2.7

2.1

130.34

131.02

g/l

0.22

306

1597

(3018405) Lactate [Moles/volume] in Arterial blood

504

3056

1.67

25.56

4.8

3.9

1.50

1.38

mmol/l

1.19

496

3000

(3014051) Protein [Presence] in Urine by Test strip

464

2754

1.71

25.49

2.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

416

2396

1.76

25.45

1.3

4.83

4.27

u/ml

0.07

180

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1002

7089

1.45

25.36

4.4

4.1

88.80

86.66

ng/l

0.27

867

6252

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11781

112558

1.28

25.32

4.6

4.2

2.79

2.83

mmol/l

5.73

10994

105576

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

632

4072

1.58

25.06

1.7

1.8

1.55

1.47

g/l

1.23

546

3484

(3014765) Yersinia sp identified in Stool by Organism specific culture

540

3351

1.64

25.03

1.2

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

8.07

24.72

1.0

0.15

0.08

u/ml

0.28

(3024891) Influenza virus A+B Ag [Presence] in Specimen

539

3357

1.63

24.62

1.2

1.1

—

(3045414) Leukocytes [Presence] in Urine

732

4895

1.52

24.56

2.0

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

639

4153

1.56

24.40

2.2

1.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

703

4671

1.53

24.30

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

539

3368

1.62

24.30

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

102

5.01

24.13

1.1

1.0

2.00

0.16

u/ml

0.56

(3022621) pH of Urine by Test strip

975

6940

1.43

23.85

3.0

2.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

404

2352

1.74

23.82

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

444

2653

1.70

23.82

1.3

1.6

2327.08

2302.07

e6/l

0.00

356

2142

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

7.41

23.71

1.0

0.16

0.09

u/ml

0.30

(3016650) Hepatitis A virus Ab [Presence] in Serum

367

2089

1.78

23.41

1.1

—

(40768443) Skin Pathology biopsy report

686

4571

1.53

23.40

1.2

—

(3036489) Thrombin time

667

4418

1.54

23.39

2.2

2.5

20.74

21.35

2.43

591

3797

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

757

5151

1.50

23.36

1.1

33.71

2.83

u/ml

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

442

2653

1.69

23.32

1.2

1.6

15.80

22.02

e6/l

0.62

334

2036

(3008037) Lactate [Moles/volume] in Venous blood

324

1779

1.84

23.28

3.7

2.9

1.50

1.56

mmol/l

0.66

316

1737

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

589

3801

1.57

23.20

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

262

1350

1.96

22.87

1.4

1.5

—

(3017732) Neutrophils [#/volume] in Blood

1096

8024

1.40

22.83

2.7

2.6

4.26

4.65

e9/l

1.85

882

6733

(3047181) Lactate [Moles/volume] in Blood

492

3056

1.63

22.74

5.5

5.7

1.41

1.26

mmol/l

2.47

449

2682

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

425

2547

1.69

22.56

1.3

51.62

42.86

u/ml

0.47

250

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

303

1652

1.85

22.29

1.8

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

474

2944

1.63

21.92

1.4

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

523

3329

1.59

21.86

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

253

1313

1.94

21.65

1.4

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

396

2356

1.70

21.62

3.5

3.7

57.38

57.00

0.25

396

2356

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

253

1316

1.94

21.51

1.4

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

356

2061

1.75

21.45

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

579

3790

1.55

21.43

2.1

1.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

253

1318

1.94

21.41

1.4

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

11174

106583

1.23

21.39

3.8

3.5

1.37

1.27

mmol/l

30.57

10383

99589

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

627

4179

1.52

21.37

5.3

4.5

24.79

24.59

mmol/l

1.10

593

3910

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11610

111226

1.25

21.20

4.2

3.9

4.65

4.72

mmol/l

10.39

10905

104910

(3024522) Salmonella sp identified in Specimen by Organism specific culture

253

1323

1.93

21.18

1.4

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

253

1324

1.93

21.13

1.4

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

280

1515

1.87

21.12

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

540

3494

1.57

21.05

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

250

1305

1.93

21.04

1.7

1.6

37.38

28.32

iu/ml

0.39

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

448

2773

1.64

21.02

1.4

1.3

274.20

255.12

u/ml

0.72

279

1744

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

187

3.60

20.60

1.3

1.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

6.31

20.50

1.1

9.47

25.48

u/ml

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11529

110488

1.24

20.24

4.2

3.8

1.41

1.46

mmol/l

33.31

10778

103845

(3024980) IgG subclass 4 [Mass/volume] in Serum

335

1948

1.74

19.90

1.6

0.75

0.71

g/l

0.27

256

1487

(3035947) Staphylolysin Ab [Units/volume] in Serum

123

495

2.50

19.85

1.2

1.1

3.60

4.06

iu/ml

0.25

(3020891) Body temperature

540

3542

1.55

19.82

6.2

4.7

—

(44813793) Dust mix specific IgE antibody measurement

192

934

2.07

19.75

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3206

27458

1.22

19.72

1.7

1.6

1.49

1.38

mmol/l

8.00

2720

23588

(3003181) Sodium [Moles/volume] in Urine

273

1512

1.82

19.16

1.7

1.5

61.09

64.45

mmol/l

0.61

212

1207

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

377

2293

1.66

18.98

1.8

1.7

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

182

883

2.08

18.87

11.7

11.8

0.57

0.60

mmol/l

0.98

170

811

(3002256) Pathology report gross observation

1722

13860

1.28

18.49

1.3

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

458

2942

1.58

18.46

1.9

2.1

10.64

10.65

mg/l

0.01

437

2758

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

152

696

2.20

18.30

1.6

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

290

1659

1.76

18.28

4.0

3.0

7.18

7.48

mmol/l

0.85

284

1623

(3007566) Smooth muscle Ab [Titer] in Serum

503

3310

1.54

18.21

1.2

1.3

103.14

121.79

titre

0.31

318

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

442

2828

1.58

18.13

2.3

2.6

—

(3008898) HLA-B27 [Presence]

708

5005

1.44

17.95

1.1

—

(3021788) Differential panel - Synovial fluid

299

1736

1.74

17.90

1.6

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

970

7240

1.36

17.87

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

343

2.69

17.39

1.1

92.80

92.13

0.08

338

(3020717) Zinc [Moles/volume] in Serum or Plasma

144

660

2.19

17.33

1.6

23.25

24.63

umol/l

0.22

134

630

(3016018) Differential panel - Cerebral spinal fluid

245

1357

1.82

17.24

1.2

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

241

1332

1.82

17.08

1.7

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

209

1105

1.90

17.03

1.7

1.6

—

(3011985) Renin [Units/volume] in Plasma

259

1466

1.78

16.96

1.5

1.6

83.43

66.16

mu/l

0.31

236

1323

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

305

1809

1.70

16.93

1.7

1.5

—

(3007700) Barley IgE Ab [Units/volume] in Serum

5.08

16.89

1.1

1.0

35.04

0.62

u/ml

0.49

(3007542) Rye IgE Ab [Units/volume] in Serum

4.82

16.79

1.1

44.97

0.23

u/ml

0.50

(4062490) Immunoglobulin typing, IgG

227

1241

1.84

16.68

1.5

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

227

1242

1.84

16.63

1.5

1.3

6.54

6.60

g/l

0.11

162

863

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

530

3596

1.49

16.63

2.7

3.2

3.54

g/l

0.02

498

3410

(3024139) IgG subclass 3 [Mass/volume] in Serum

226

1242

1.83

16.34

1.5

1.3

0.35

0.39

g/l

1.41

160

861

(3028192) IgG subclass 2 [Mass/volume] in Serum

226

1242

1.83

16.34

1.5

1.3

2.85

2.93

g/l

0.26

161

866

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

276

2.84

16.31

3.4

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

276

2.84

16.31

3.4

2.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

385

2458

1.58

15.98

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

119

522

2.29

15.95

1.3

142.69

135.01

nmol/l

0.83

119

522

(3034770) Mitochondria Ab [Titer] in Serum

482

3239

1.51

15.86

1.2

1.3

811.54

989.09

titre

0.14

(3019977) pH of Arterial blood

112

482

2.33

15.70

3.4

2.8

7.40

7.42

1.14

154

(3020961) Endomysium IgA Ab [Titer] in Serum

872

6537

1.36

15.61

1.1

132.86

222.37

titre

0.80

180

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

520

3567

1.48

15.47

2.8

2.9

174.21

179.49

0.70

494

3383

(40759836) Histone Ab [Presence] in Serum by Immunoblot

177

915

1.95

15.47

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

239

1360

1.77

15.42

1.4

737.53

403.76

pmol/l

0.36

209

1189

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

177

917

1.94

15.37

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

295

1782

1.67

15.33

1.5

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

177

919

1.94

15.28

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

263

1547

1.71

15.10

3.2

3.3

1.15

1.51

1.09

223

1392

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

177

925

1.93

15.00

1.2

—

(3023419) Bacteria identified in Sputum by Culture

223

1255

1.79

14.95

2.3

2.7

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

177

926

1.92

14.95

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

315

1951

1.63

14.86

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

177

928

1.92

14.86

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

678

4927

1.40

14.72

2.4

2.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

426

2838

1.52

14.64

3.4

4.1

0.34

u/ml

0.05

232

1587

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

379

2465

1.55

14.54

2.8

3.2

34.83

47.77

mg/l

1.30

297

1989

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

138

671

2.07

14.35

2.7

3.0

87.61

111.12

nmol/l

0.67

131

664

(3004716) Salmonella sp identified in Stool by Organism specific culture

941

7227

1.32

14.30

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

175

927

1.90

14.26

1.2

1.3

1.78

1.95

mmol/l

3.04

162

869

(3011648) Oxygen content in Venous blood

161

830

1.95

14.23

2.1

4.1

11.08

11.19

0.11

161

830

(3034860) Kappa light chains.free [Mass/volume] in Serum

377

2466

1.54

14.11

2.8

3.2

51.65

75.07

mg/l

0.49

294

1986

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

172

912

1.90

13.99

15.2

13.2

6543.28

822.95

nmol/l

0.49

166

878

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

209

1179

1.78

13.94

2.1

2.5

23.47

20.26

nmol/l

2.55

195

1126

(3039162) Centromere protein B Ab [Units/volume] in Serum

251

1493

1.69

13.88

1.3

31.61

53.22

u/ml

0.49

105

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

368

2404

1.55

13.87

2.7

3.1

1.30

2.51

ratio

1.44

216

(3049717) Cytology report of Urine Cyto stain

426

2878

1.50

13.71

2.5

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

176

947

1.87

13.69

20.2

19.0

14170.64

2403.14

nmol/l

0.65

169

915

(3004616) Nuclear Ab [Presence] in Serum

231

1349

1.72

13.66

1.3

—

(3023410) Appearance of Cerebral spinal fluid

220

1275

1.74

13.38

1.3

1.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

367

2419

1.53

13.29

1.6

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

307

1946

1.59

13.22

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

105

476

2.21

13.10

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

194

1091

1.79

13.10

1.2

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

156

820

1.91

13.06

1.3

1.2

67.14

69.10

u/ml

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

225

1324

1.71

12.97

1.1

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

211

1221

1.74

12.92

6.1

7.1

10.84

11.05

mg/l

0.26

196

1131

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

156

825

1.90

12.83

1.3

1.2

62.80

38.88

u/ml

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

173

946

1.84

12.82

2.8

2.2

—

(3038026) Centromere Ab [Units/volume] in Serum

158

841

1.89

12.74

1.3

1.2

73.80

43.34

u/ml

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

546

3926

1.41

12.65

1.7

1.6

2.04

6.72

iu/ml

0.51

105

812

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

333

2173

1.55

12.65

1.4

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

119

575

2.08

12.65

1.4

1.2

318.28

294.09

u/l

0.12

109

525

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

125

616

2.04

12.60

1.1

10.00

10.77

u/ml

0.07

120

(3017354) Segmented neutrophils/100 leukocytes in Blood

171

937

1.84

12.60

3.0

3.3

57.05

55.92

0.28

137

799

(3034274) Bile acid [Moles/volume] in Serum --fasting

377

2531

1.50

12.55

2.1

2.3

8.02

6.42

umol/l

0.61

276

1858

(3006840) Garlic IgE Ab [Units/volume] in Serum

17.29

12.48

1.1

1.0

0.13

0.07

u/ml

—

(3000475) Leukocytes [#/volume] in Synovial fluid

342

2259

1.53

12.30

1.7

1.6

14261.73

13561.73

e6/l

0.08

230

1629

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

149

790

1.90

12.18

1.3

1.2

17.25

11.21

u/ml

0.23

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

131

665

1.98

12.18

1.3

1.5

5.62

6.03

u/l

0.38

110

566

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

536

3869

1.40

12.16

2.5

3.1

93.45

93.46

0.00

517

3725

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

173

963

1.81

12.13

1.1

1.3

193.75

206.00

titre

0.06

180

(3021661) Pineapple IgE Ab [Units/volume] in Serum

15.86

12.11

1.1

1.0

0.32

0.02

u/ml

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

122

606

2.02

12.06

2.1

2.2

2.06

1.87

umol/l

1.62

116

572

(3045716) Anion gap in Serum or Plasma

412

2.24

11.87

2.9

2.4

10.11

9.90

mmol/l

0.17

403

(3044941) Cell count panel - Synovial fluid

237

1452

1.64

11.78

1.5

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

108

520

2.09

11.63

1.2

176.64

159.11

mmol/24h

1.04

108

520

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

404

2795

1.46

11.60

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

163

904

1.81

11.59

1.6

1.4

1.67

1.44

nmol/l

1.52

145

805

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

218

2.71

11.50

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

267

1695

1.59

11.49

1.6

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

142

759

1.88

11.36

1.5

1.4

72.67

79.14

umol/l

2.33

142

759

(3019832) Treponema pallidum Ab [Presence] in Serum

2230

19338

1.18

11.16

1.8

1.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

150

821

1.84

11.15

1.0

1.1

—

(1002224) Polysomnography panel

695

5301

1.33

11.12

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

148

809

1.84

11.05

3.8

4.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

304

2006

1.53

11.03

1.3

1.2

3.35

3.70

u/ml

0.15

110

674

(3029634) Reagin Ab [Titer] in Serum by VDRL

307

2037

1.52

10.87

1.9

2.0

2.67

7.61

titre

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

150

828

1.82

10.86

1.0

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

350

2387

1.48

10.84

5.7

5.8

777.36

1429.31

iu/ml

0.35

308

(3023323) Follitropin [Units/volume] in Serum or Plasma

972

7780

1.27

10.78

1.4

22.35

24.74

iu/l

1.63

815

6657

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

184

1082

1.71

10.73

2.7

3.2

4.96

9.70

nmol/l

0.44

176

1050

(40761535) Cells panel - Urine sediment

999

8037

1.26

10.61

3.8

3.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

247

1570

1.58

10.61

1.1

1.46

1.49

g/l

0.44

233

1431

(21491868) Cryoglobulin [Mass/volume] in Serum

387

2.20

10.59

1.2

0.16

0.22

g/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1946

16754

1.19

10.56

1.6

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

158

896

1.77

10.48

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

199

1203

1.66

10.47

1.5

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

147

816

1.81

10.47

2.8

2.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

396

2786

1.43

10.44

1.5

1.4

8.33

22.88

u/ml

—

(3044242) Glucose [Moles/volume] in Arterial blood

403

2.17

10.40

3.1

2.1

—

(3003694) ABO and Rh group [Type] in Blood

3988

36277

1.14

10.35

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

228

1431

1.60

10.34

1.5

1.4

—

(21494755) Public health laboratory ask at order entry panel

1272

15251

0.82

10.31

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1431

12005

1.21

10.28

4.2

3.9

31.24

32.10

2.40

1089

8638

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1020

8264

1.25

10.19

2.3

2.1

11.53

12.09

nmol/l

1.39

907

7482

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

107

542

1.98

10.09

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

155

885

1.76

10.06

1.3

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

312

2114

1.49

10.02

2.3

0.88

0.81

nmol/l

0.63

251

1791

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

292

1952

1.51

10.02

1.3

2.99

4.12

u/ml

1.47

132

855

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

317

2161

1.48

9.88

1.2

1.1

10.52

10.96

au/ml

0.06

146

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

268

1765

1.53

9.87

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

300

2024

1.49

9.85

1.8

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

210

1311

1.61

9.76

1.6

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

143

805

1.78

9.76

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

143

805

1.78

9.76

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

143

805

1.78

9.76

1.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

290

1948

1.50

9.73

3.5

3.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

153

882

1.74

9.63

1.3

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

428

3103

1.39

9.54

1.8

1.9

3.10

6.76

iu/l

0.83

150

1239

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

256

1684

1.53

9.50

1.8

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

256

1684

1.53

9.50

1.8

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

480

2.01

9.42

1.6

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

487

2.00

9.42

1.6

1.5

—

(3017509) Phencyclidine [Presence] in Urine

213

2.54

9.32

2.7

1.9

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

202

2.58

9.26

1.1

0.64

0.71

umol/24h

0.58

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

272

1823

1.50

9.25

3.5

3.3

289.06

1695.15

u/ml

1.70

(3003338) MCHC [Mass/volume]

10761

104221

1.14

9.25

21.8

15.0

332.75

333.07

g/l

3.15

10713

103431

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

294

2003

1.48

9.23

1.5

1.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

397

2.10

9.19

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

364

2588

1.42

9.11

1.5

112.45

110.42

u/ml

0.09

533

(3039000) Anion gap in Blood

300

2058

1.47

9.10

6.8

6.9

11.66

11.22

mmol/l

1.14

276

1831

(3018572) Chloride [Moles/volume] in Blood

300

2059

1.47

9.08

6.8

6.9

104.54

105.33

mmol/l

1.77

276

1832

(3040151) Glucose [Moles/volume] in Capillary blood

180

1110

1.63

8.84

14.2

11.0

7.80

7.28

mmol/l

0.30

155

912

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

6.90

8.52

1.1

1.2

—

mmol/l

—

(3037756) Immunofixation for Serum or Plasma

242

1613

1.51

8.49

1.8

1.6

—

(3008295) Osmolality of Serum or Plasma

169

1038

1.64

8.46

1.6

1.5

278.80

281.52

mosm/kgh2o

0.80

127

805

(3016244) Insulin [Units/volume] in Serum or Plasma

163

993

1.65

8.43

3.0

3.4

25.58

27.41

mu/l

0.23

154

937

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

158

957

1.66

8.36

1.0

1.1

283.92

287.91

mg/l

0.28

146

865

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

174

1080

1.62

8.36

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

259

1759

1.48

8.31

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

114

631

1.81

8.30

1.1

1.37

7.53

nmol/l

1.42

129

(1761482) Bacteria [#/volume] in Urine by Culture

310

2180

1.43

8.29

4.2

3.8

—

(21494815) CD4 cells/100 lymphocytes in Specimen

172

1071

1.61

8.17

2.0

2.5

41.53

39.65

0.94

167

1056

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

272

2.25

8.10

1.3

103.80

117.84

nmol/l

0.38

205

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

508

1.90

8.07

2.1

2.3

138.33

154.75

nmol/l

0.79

437

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

392

2.02

7.99

3.7

4.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

484

1.91

7.88

2.0

2.8

1.03

1.32

ug/l

0.74

455

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

116

658

1.77

7.81

1.8

126.64

133.32

0.49

111

614

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

272

1891

1.45

7.77

1.1

120.72

116.13

1.58

244

1712

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

488

1.89

7.70

1.9

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

489

1.89

7.65

1.9

2.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

691

5540

1.26

7.62

1.3

215.60

229.52

miu/ml

0.46

300

2659

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.59

7.55

2.2

1.5

44.75

41.18

umol/l

0.21

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

240

1638

1.47

7.55

1.3

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

132

786

1.69

7.50

2.3

2.6

97.50

97.43

0.01

127

727

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

206

2.38

7.47

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.09

7.46

1.0

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

208

1384

1.51

7.42

1.1

94.61

95.29

0.13

195

1301

(3020911) Cortisol [Moles/time] in 24 hour Urine

438

1.92

7.41

1.3

1.4

88.49

151.74

nmol/24h

0.92

438

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1070

9008

1.20

7.41

3.8

4.0

17.43

25.25

ug/l

0.37

840

7056

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

279

1971

1.42

7.33

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

148

915

1.62

7.29

2.0

2.4

—

(3016330) Potassium [Moles/time] in 24 hour Urine

169

2.49

7.05

1.1

1.3

—

96.20

—

(3037121) Protein [Mass/volume] in Urine

468

3609

1.31

7.05

3.4

3.3

0.28

0.35

g/l

1.05

219

1635

(3011412) CD3 cells [#/volume] in Blood

185

1217

1.53

6.99

2.2

2.7

1.32

1.25

e9/l

0.54

161

1061

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

177

1154

1.54

6.97

2.2

2.0

23.03

25.42

mg/l

0.23

301

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

174

1132

1.54

6.92

1.2

32.58

40.34

mg/l

2.56

140

941

(40760888) Immunoglobulin light chains.free panel - Serum

265

1876

1.42

6.91

3.0

3.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

170

1102

1.55

6.88

1.1

220.21

243.76

mg/l

1.16

146

976

(43055442) Apixaban [Mass/volume] in Serum or Plasma

3.05

6.87

1.4

1.5

122.09

117.40

ug/l

0.06

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

165

1063

1.56

6.86

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

663

1.71

6.82

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

176

1155

1.53

6.74

1.6

56.32

54.62

0.20

105

727

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

142

887

1.61

6.74

1.2

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

260

1844

1.42

6.72

1.8

1.9

5.06

5.24

mmol/24h

0.39

230

1657

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

137

849

1.62

6.72

1.1

7.72

8.30

iu/ml

0.08

211

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

3.88

6.69

1.2

1.1

398.64

74.14

u/l

0.41

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

164

1064

1.55

6.63

1.2

—

(3045142) Bone marrow Pathology biopsy report

155

993

1.57

6.62

1.3

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

155

993

1.57

6.62

1.9

2.4

74.21

73.52

0.26

149

958

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

174

1144

1.53

6.62

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

109

640

1.71

6.58

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

590

4729

1.26

6.57

1.5

1.4

9.60

9.28

u/l

0.22

482

3851

(3000093) Morphology [Interpretation] in Blood Narrative

144

910

1.59

6.53

1.1

—

(3000012) Reticulocyte production index

176

1164

1.52

6.52

2.4

2.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

142

896

1.59

6.48

1.8

1.6

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

103

600

1.72

6.41

1.4

72.52

72.41

0.03

574

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

491

1.80

6.35

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

970

8212

1.19

6.34

2.9

2.4

68.35

71.42

ml/min/173m2

1.31

360

3143

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

486

3826

1.28

6.29

1.1

5.82

5.63

u/ml

0.04

548

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

138

872

1.59

6.28

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

283

2.05

6.24

1.2

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

317

1.99

6.23

1.4

1.3

17.38

16.86

umol/l

0.22

282

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

102

599

1.71

6.18

1.5

35.58

19.70

u/ml

0.62

121

(3028679) Herpes simplex virus Ab [Presence] in Serum

126

783

1.61

6.15

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

158

1039

1.53

6.05

3.4

3.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

100

588

1.71

6.04

1.4

601.13

488.40

mu/l

0.50

562

(3017569) Oxygen content in Arterial blood

370

1.90

6.02

2.8

2.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

234

2.14

6.00

1.4

1.6

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

509

1.75

5.94

1.3

28.33

56.22

titre

—

(3036071) Salmonella sp Ab [Titer] in Serum

422

1.83

5.92

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

210

1471

1.43

5.88

1.2

1.1

1.71

1.87

iu/ml

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.11

5.87

1.1

—

(3012441) Differential panel - Pleural fluid

120

746

1.61

5.87

1.6

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

129

817

1.58

5.85

2.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

388

1.86

5.85

2.8

2.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

266

1944

1.38

5.83

1.1

76.43

5430.07

iu/ml

0.64

500

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

105

633

1.66

5.80

1.4

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

354

1.90

5.78

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

252

2.07

5.73

1.1

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

219

2.15

5.72

1.4

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

322

2434

1.33

5.68

1.2

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

526

1.72

5.59

1.3

134.00

398.00

titre

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

367

1.86

5.52

1.3

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

320

2433

1.32

5.44

1.2

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

335

1.88

5.36

2.1

2.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

109

679

1.61

5.33

1.2

—

(3016038) Potassium [Moles/volume] in Urine

100

610

1.64

5.32

1.9

1.4

33.96

34.82

mmol/l

0.13

540

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

147

981

1.50

5.31

1.1

—

(3045424) Erythrocytes [Presence] in Urine

250

1840

1.37

5.29

1.6

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

138

913

1.52

5.20

1.2

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

158

1076

1.47

5.18

3.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

457

1.73

5.13

1.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

3.75

5.08

1.1

0.22

0.20

g/l

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.08

5.05

1.3

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

179

1255

1.43

5.05

1.1

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

238

2.02

5.02

1.1

1.2

—

(3010503) CD19 cells [#/volume] in Blood

108

683

1.59

4.99

2.6

2.7

0.21

0.25

e9/l

0.19

103

664

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

133

882

1.51

4.98

2.2

2.9

828.32

732.50

e6/l

1.07

127

859

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

133

883

1.51

4.95

1.5

1.6

30.55

32.90

0.29

536

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

129

2.41

4.95

2.3

3.4

45.41

41.40

umol/l

0.32

109

(3027923) C peptide [Moles/volume] in Serum or Plasma

539

1.66

4.90

1.6

1.8

1.11

1.28

nmol/l

0.83

423

(3025018) Bordetella pertussis Ab [Titer] in Serum

121

789

1.54

4.90

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

162

1122

1.45

4.89

1.8

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

449

1.72

4.88

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

284

2160

1.32

4.86

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1612

14468

1.13

4.84

1.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

158

1092

1.45

4.83

1.3

1.4

—

titre

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

377

1.78

4.81

1.0

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

146

995

1.47

4.80

1.9

1.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

397

3160

1.26

4.80

3.2

3.6

1231.50

2112.42

u/ml

0.36

344

2707

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1149

13041

0.87

4.78

1.6

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

141

957

1.48

4.74

1.6

2.2

19.83

23.65

ug/l

0.69

136

942

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

258

1.94

4.70

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

470

1.68

4.67

1.1

94.31

93.28

0.13

206

(21494814) CD8 cells/100 lymphocytes in Specimen

441

1.70

4.64

2.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

152

1052

1.45

4.63

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.58

4.62

1.1

1.80

1.71

umol/24h

0.18

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

457

1.69

4.60

1.1

1.2

92.65

93.54

0.07

206

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

504

1.65

4.56

1.3

1.2

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

190

1374

1.39

4.54

2.5

2.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

143

983

1.46

4.53

1.7

1.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

178

1277

1.40

4.47

1.3

1.4

8.00

7.75

mmol/l

0.37

172

1244

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2519

23278

1.10

4.40

1.5

—

(3034988) Calcium [Moles/volume] in Capillary blood

209

2.01

4.39

1.5

3.3

1.16

1.19

mmol/l

2.75

198

(3028308) Erythrocytes [#/volume] in Pleural fluid

116

773

1.50

4.31

1.6

1.4

25891.42

57092.36

e6/l

1.38

450

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

246

1.91

4.27

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

246

1.91

4.27

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

246

1.91

4.27

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

246

1.91

4.27

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

407

1.70

4.25

1.3

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

178

2.08

4.24

1.3

—

(3012565) Volume of 24 hour Urine

524

1.61

4.18

2.1

2134.28

2011.35

0.39

479

(3023199) Leukocytes [#/volume] in Pleural fluid

127

868

1.47

4.18

1.5

1.4

2750.38

2423.98

e6/l

0.14

627

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.74

4.17

1.5

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

327

2592

1.27

4.15

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

451

3713

1.22

4.07

1.8

1.7

36.76

40.87

nmol/l

3.37

442

3629

(3042631) Mycobacterium sp identified in Specimen

157

1122

1.40

4.07

2.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

268

2079

1.29

4.05

1.1

4.15

3.00

u/ml

0.59

103

1076

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.19

4.05

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

499

1.61

4.00

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

124

2.26

3.95

7.9

11.2

5.40

5.72

mmol/l

0.34

124

(3003434) Protein [Mass/volume] in Pleural fluid

137

963

1.43

3.91

1.5

1.4

33.54

33.47

g/l

0.02

123

870

(3030313) Adrenal Ab [Titer] in Serum

138

2.18

3.88

1.2

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

465

1.62

3.86

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

465

1.62

3.86

1.3

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

123

850

1.45

3.85

1.0

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

165

1203

1.38

3.82

1.7

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

165

1203

1.38

3.82

1.7

1.6

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

382

1.68

3.82

1.2

1.3

33.75

17.37

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

278

2187

1.28

3.79

2.3

138.29

113.09

ug/min

0.35

159

1373

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

107

725

1.48

3.72

1.5

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

780

8929

0.87

3.71

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

171

1261

1.36

3.71

3.1

3.0

0.86

0.82

nmol/l

0.61

130

940

(3013247) Albumin in CSF/Albumin in Serum or Plasma

318

1.73

3.69

1.1

5.72

6.31

mg/g

0.40

307

(40768441) Liver Pathology biopsy report

117

811

1.45

3.63

1.3

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

142

2.12

3.63

1.0

1.3

30.47

42.39

mg/l

1.00

123

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

608

1.52

3.62

1.3

1.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

123

2.20

3.59

1.4

1.7

0.89

2.23

mg/l

1.69

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

228

1763

1.30

3.58

2.9

3.5

315.43

554.13

u/ml

0.62

203

1615

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

303

2428

1.25

3.57

1.4

19.90

23.57

u/l

1.36

256

2020

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

306

2455

1.25

3.57

2.0

1.8

197.18

192.06

pmol/l

0.27

292

2335

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

595

1.52

3.54

1.3

1.4

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

301

1.73

3.49

1.2

80.45

71.22

0.44

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

377

1.65

3.48

2.1

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

377

1.65

3.48

2.1

2.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

243

1.81

3.46

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2628

24584

1.08

3.45

4.4

2.43

2.83

ug/l

0.52

2331

22248

(3042733) HLA Ab [Presence] in Serum

409

1.62

3.44

4.2

4.8

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

119

2.19

3.43

1.3

1.7

3.51

1.93

mg/l

0.42

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

119

2.19

3.43

1.3

1.7

0.25

1.05

mg/l

2.69

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

119

2.19

3.43

1.3

1.7

1.57

1.78

mg/l

0.12

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

119

2.19

3.43

1.3

1.7

0.50

1.31

mg/l

1.15

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

119

2.19

3.43

1.3

1.7

1.13

1.88

mg/l

0.95

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

119

2.19

3.43

1.3

1.7

3.35

4.17

mg/l

0.29

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

119

2.19

3.43

1.3

1.7

1.67

3.28

mg/l

0.96

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

119

2.19

3.43

1.6

1.9

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

119

2.19

3.43

1.3

1.7

0.45

2.52

mg/l

3.80

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

119

2.19

3.43

1.3

1.7

0.92

2.41

mg/l

1.96

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

194

1.91

3.41

2.5

2.6

1.33

1.51

mmol/l

0.19

144

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

385

3183

1.22

3.40

5.3

1.49

1.38

mg/l

2.02

354

2988

(3024263) Appearance of Synovial fluid

521

1.54

3.39

1.2

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

459

1.57

3.35

1.6

1.5

5.38

4.18

—

112

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

5.72

3.34

1.0

—

(3020491) Glucose [Moles/volume] in Blood

120

851

1.41

3.33

1.6

1.9

6.56

6.24

mmol/l

0.52

641

(4035726) Immunohistochemistry procedure

974

8687

1.13

3.30

1.4

—

(3044927) Protein electrophoresis panel - Urine

112

786

1.43

3.29

1.2

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

646

1.47

3.29

1.8

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

129

929

1.39

3.28

2.2

2.8

527.60

523.41

e6/l

0.04

103

763

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

384

1.62

3.26

2.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

183

1394

1.32

3.24

1.5

1.7

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

122

873

1.40

3.23

1.3

1.4

11.08

11.66

umol/l

0.58

113

834

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

116

2.16

3.21

1.1

—

(40759632) Porphyrins [Mass/mass] in Stool

6.37

3.18

1.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.80

3.18

1.2

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

214

1.82

3.16

1.8

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

373

1.61

3.13

2.2

2.9

28.39

28.74

umol/l

0.09

274

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

381

1.60

3.12

3.1

2.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

131

2.06

3.11

1.3

1.2

—

(3051651) Icteric interference index of Serum or Plasma

663

1.45

3.10

3.9

3.6

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

194

1.86

3.09

1.1

1.0

—

(3004775) Volume in Urine collected for unspecified duration

101

705

1.44

3.08

2.2

738.45

637.87

0.76

503

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

493

1.52

3.08

2.1

2.2

8.82

9.52

mg/l

0.50

404

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

454

1.54

3.06

2.4

2.0

37.71

149.84

ug/min

1.25

105

(40768446) Kidney Pathology biopsy report

478

1.53

3.06

1.8

1.7

—

(40768806) Pleura Pathology biopsy report

108

765

1.41

3.05

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

552

1.49

3.02

1.7

1.6

1.65

2.93

u/field

1.48

396

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

292

1.68

3.01

1.6

10.16

8.81

ug/l

0.85

292

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

292

1.68

3.01

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

621

7109

0.87

3.01

1.5

1.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

570

1.48

2.98

1.5

1.7

4.42

3.83

nmol/l

0.09

469

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

301

1.66

2.97

1.4

1.1

101.56

81.81

—

(3045788) Cell count panel - Pleural fluid

680

1.43

2.92

1.6

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

130

960

1.36

2.88

1.4

1.3

4.50

5.64

umol/l

3.23

116

897

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

198

1556

1.28

2.83

1.2

1.3

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

313

1.63

2.83

1.2

105.82

104.34

0.17

296

(3000060) B lymphocytes [#/volume] in Blood

447

1.52

2.82

1.8

2.8

219.33

280.45

e6/l

0.52

243

(40757494) Bilirubin.total [Moles/volume] in Blood

528

1.48

2.82

2.6

2.3

15.94

57.48

umol/l

4.10

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

112

811

1.38

2.81

1.5

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

114

828

1.38

2.81

1.2

1.08

1.06

ratio

0.71

280

(3028717) Thiamine [Mass/volume] in Blood

123

2.03

2.80

1.1

1.2

—

(3016750) Collection duration of Urine

529

1.48

2.80

2.1

2.2

519.09

500.06

min

0.81

413

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

172

1.86

2.80

1.2

1.6

107.67

64.81

ng/l

0.44

106

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

103

2.14

2.79

2.8

3.5

1.23

1.30

mg/l

0.05

(3002621) Streptococcal DNAse B [Units/volume] in Serum

130

2.00

2.79

1.1

—

(3014891) Appearance of Pleural fluid

2.20

2.72

1.3

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

111

2.07

2.72

1.5

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

306

2539

1.21

2.69

1.2

1.3

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

4.21

2.67

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

249

1.69

2.67

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

669

1.41

2.64

1.1

1.2

15.58

17.04

u/ml

0.04

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.46

2.61

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

162

1.85

2.61

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

282

1.63

2.59

1.2

1.1

—

330.00

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

122

910

1.34

2.58

2.2

2.9

0.22

e9/l

0.05

101

762

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

107

2.06

2.56

1.0

1.1

55.47

43.42

mg/l

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

624

1.41

2.53

1.2

1.3

58.00

71.10

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

508

1.46

2.53

1.3

14.74

12.31

u/l

0.64

468

(3020393) Adenovirus Ag [Presence] in Stool

186

1.78

2.51

1.8

1.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

277

1.63

2.50

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

277

1.63

2.50

1.2

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

277

1.63

2.50

1.8

1.7

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

277

1.63

2.50

1.2

1.1

—

(3004451) EKG impression Narrative

396

1.52

2.49

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

120

899

1.34

2.48

2.6

2.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

208

1675

1.25

2.47

2.4

2.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

454

1.48

2.46

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

133

1013

1.32

2.46

3.0

2.5

1.32

1.58

g/24h

0.60

522

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.38

2.45

1.0

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

713

1.38

2.44

1.3

7.09

6.25

mmol/l

1.61

659

(4034850) Laboratory test

396

3402

1.17

2.39

9.1

8.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

101

742

1.36

2.38

1.1

1.04

1.05

u/l

0.10

332

(3035153) Lemon IgE Ab [Units/volume] in Serum

6.25

2.37

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

3.03

2.35

1.3

2.9

4.30

4.49

mmol/l

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

126

960

1.32

2.34

1.4

1.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.25

2.33

1.3

1.2

—

(3014271) Vancomycin [Susceptibility]

378

1.51

2.33

3.0

2.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

244

2016

1.21

2.30

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

429

1.47

2.28

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.12

2.28

1.2

1.1

21.15

22.79

u/l

0.12

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

597

5301

1.13

2.27

2.0

1.9

—

(3002619) Bacteria identified in Specimen by Culture

224

1.65

2.23

1.3

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

346

4033

0.85

2.23

1.4

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.04

2.21

1.9

2.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.50

2.18

1.3

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.13

2.18

1.1

2.4

1.56

70.22

pmol/l

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.33

2.17

3.0

1.4

4.82

2.55

mu/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

180

1.72

2.17

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

188

1.70

2.16

1.1

1.3

29.50

102.46

titre

—

(3032057) Clostridioides difficile [Presence] in Stool

188

1.70

2.16

1.8

1.9

—

(3026250) Tacrolimus [Mass/volume] in Blood

568

1.39

2.16

44.2

35.8

7.12

7.31

ug/l

0.44

526

(3041806) Other cells [#/volume] in Blood by Manual count

887

0.70

2.15

1.6

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

535

1.40

2.14

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

444

1.44

2.13

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

235

1.62

2.12

6.8

6.2

—

(3009677) Dengue virus Ab [Presence] in Serum

2.36

2.11

1.1

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

291

1.55

2.10

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

145

1.79

2.09

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.70

2.06

1.0

—

(40768795) Lymph node Pathology biopsy report

131

1024

1.28

2.06

1.2

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.50

2.05

1.1

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

407

1.45

2.04

2.9

2.7

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.40

2.02

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

252

2119

1.19

2.02

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

739

1.33

2.01

1.2

1.3

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.22

2.00

1.0

1.3

0.22

0.85

umol/24h

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

467

1.42

2.00

1.2

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

148

1.76

1.97

7.8

8.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

163

1.72

1.97

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

187

1.66

1.93

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

745

1.32

1.91

1.9

2.33

1.80

u/field

0.40

339

(3028433) Virus identified in Specimen by Culture

388

1.45

1.91

1.1

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

616

1.35

1.91

2.0

—

(3009871) Measles virus Ab [Titer] in Serum

456

1.41

1.88

1.8

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

332

1.48

1.87

2.4

9.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

739

1.31

1.87

1.4

1.2

—

(3024316) Viscosity of Plasma

2.31

1.87

3.1

1.3

1.55

1.65

mpas

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

653

1.33

1.86

1.2

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

457

1.40

1.86

1.2

1.1

66.36

438.69

ng/l

1.13

107

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.94

1.84

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.98

1.84

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

190

1.63

1.83

1.2

0.65

70.73

mg/l

1.20

137

(3004446) Plasmodium sp identified in Blood by Light microscopy

130

1.77

1.81

2.8

2.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

569

5120

1.12

1.80

1.6

4.66

3.89

mg/l

0.90

435

3640

(3010144) Erythrocytes [#/volume] in Synovial fluid

112

876

1.28

1.79

1.3

1.4

117981.74

85203.88

e6/l

0.20

604

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.13

1.71

1.2

1.4

36.94

23.86

nmol/l

0.42

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

449

5031

0.89

1.70

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

242

1.53

1.69

1.2

302.28

319.62

pmol/l

0.09

175

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

332

1.45

1.69

1.1

49.32

57.70

u/ml

0.49

322

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

463

5172

0.89

1.67

1.6

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

605

1.32

1.66

1.3

1.2

17.85

19.78

u/l

0.23

517

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

3.16

1.66

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.03

1.64

1.4

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

686

1.30

1.62

1.1

—

(3017704) Immunofixation for Urine

428

1.38

1.61

1.7

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

557

1.33

1.60

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

654

1.30

1.58

2.3

2.8

43.57

42.42

0.24

364

(1761868) Lipid panel - Serum or Plasma

4252

43794

0.96

1.56

2.6

2.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

630

1.30

1.55

1.3

1.2

76.09

85.64

u/l

0.69

552

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.43

1.53

6.1

8.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

737

1.28

1.53

1.7

1.8

3.00

3.77

mg/l

1.63

705

(40762814) Titanium [Mass/volume] in Blood

115

1.74

1.52

2.6

2.3

3.01

4.17

ug/l

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.83

1.51

1.0

1.1

—

(3024932) HLA-DR beta [Type]

408

1.37

1.51

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

116

1.73

1.48

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

359

1.39

1.47

1.6

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

124

1.69

1.46

1.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

479

1.34

1.46

2.1

5.9

75.38

1263.87

mg/l

1.04

351

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.22

1.46

13.3

9.5

—

(3033799) Differential panel - Peritoneal fluid

268

1.46

1.45

2.1

2.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.50

1.45

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

682

6273

1.09

1.45

2.7

3.0

32.56

43.86

u/ml

2.01

657

6059

(3047189) Immunofixation for 24 hour Urine

369

1.38

1.44

2.3

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

125

1.68

1.43

1.1

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

118

960

1.23

1.42

1.3

143.84

189.08

pmol/l

2.99

118

960

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

405

1.36

1.40

1.9

1.8

281.33

147.69

au/ml

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

149

1.61

1.40

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.85

1.39

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

189

1.54

1.39

1.1

1.2

39.98

320.09

ug/l

1.20

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

432

4783

0.90

1.38

1.8

—

(3024471) HLA-A [Type]

415

1.35

1.38

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

793

0.76

1.38

1.2

1.3

1.53

1.55

g/l

0.17

793

(3013762) Body weight Measured

2.20

1.36

1.3

1.2

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

104

1.73

1.36

1.0

1.1

46.52

33.70

u/ml

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

314

1.40

1.36

1.7

1.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.94

1.36

1.0

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

548

1.30

1.33

2.4

47.53

50.83

umol/l

0.35

489

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

1.67

1.33

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

461

1.32

1.33

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

681

1.26

1.33

1.1

1425.30

1487.56

miu/ml

0.22

681

(3035933) Granulocytes/100 leukocytes in Blood

437

1.33

1.30

2.0

1.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

209

1.48

1.29

1.6

1.5

—

(36303858) Crystals [Presence] in Urine

2.78

1.28

1.4

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

552

1.29

1.28

2.7

2.9

194.23

129.99

au/ml

0.43

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.08

1.27

7.4

6.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

260

1.42

1.26

1.1

—

(3025130) Human papilloma virus identified in Specimen

236

2067

1.14

1.25

1.7

1.8

—

(3006462) Nitrate [Presence] in Urine

528

1.29

1.24

2.6

2.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

100

1.70

1.23

2.9

2.1

0.76

0.69

u/field

0.11

100

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

172

1.51

1.20

1.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.31

1.18

2.5

5.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.11

1.18

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

206

1.46

1.17

1.3

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

190

1.47

1.15

1.6

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

318

1.35

1.12

1.1

—

(3034614) HLA Ag [Interpretation]

2.33

1.12

1.1

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

168

1450

1.16

1.12

1.5

1.3

38.57

35.01

u/l

0.09

145

1261

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

1.78

1.10

1.5

1.8

46.50

63.26

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.78

1.10

4.8

4.5

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.26

1.10

1.1

1.4

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.67

1.10

1.1

—

2.02

—

(3006270) Folate [Moles/volume] in Blood

101

836

1.21

1.09

1.1

358.55

382.96

nmol/l

0.66

744

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

617

0.76

1.09

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1483

14173

1.05

1.08

2.8

0.66

0.73

ug/l

2.59

932

8667

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.19

1.08

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

125

1472

0.85

1.07

1.4

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.87

1.07

3.0

5.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

137

1169

1.17

1.07

3.8

4.7

41.02

92.79

u/ml

2.36

388

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

323

1.33

1.03

1.4

1.5

5.88

5.70

nmol/l

0.07

312

(3007919) Fasciola sp Ab [Titer] in Serum

2.27

1.03

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

242

2711

0.89

1.03

1.3

3.54

3.76

ug/l

0.17

223

2489

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

300

2707

1.11

1.03

1.8

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.63

1.03

1.1

1.3

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

1.83

1.02

1.2

1.7

37.40

17.59

—

(3036670) Protein [Mass/volume] in Synovial fluid

255

1.37

1.02

1.1

1.2

38.89

39.23

g/l

0.04

137

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

127

1083

1.17

1.01

1.2

57.78

66.87

u/l

1.02

113

976

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.89

1.01

1.2

2.3

—

(3020650) Glucose [Presence] in Urine

335

1.31

0.98

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

140

1.50

0.97

1.4

1.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

116

1.55

0.96

2.6

3.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

267

1.35

0.95

1.2

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.95

0.0

1.2

—

3737.05

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.77

0.94

3.5

3.3

—

(3049233) Organic acids panel - Urine

1.89

0.94

1.1

1.3

—

(40768793) Breast Pathology biopsy report

278

2515

1.11

0.93

1.2

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

606

1.22

0.93

1.0

98.17

93.96

0.52

487

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

534

1.24

0.92

1.0

792.98

739.48

ng/l

0.49

371

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2019

19514

1.04

0.92

3.7

3.8

21.50

21.81

0.34

829

8505

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

142

1.48

0.92

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

170

0.59

0.89

8.2

6.6

71.60

71.44

—

137

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

537

1.23

0.89

1.0

44.11

42.84

ng/l

0.10

378

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

131

1135

1.16

0.88

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.69

0.88

5.1

4.4

—

(4146454) Self-monitoring of blood glucose

104

885

1.18

0.88

2.8

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.00

0.87

1.5

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.00

0.87

3.3

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

237

2625

0.90

0.86

1.2

—

(21494434) Karyotype in Bone marrow

767

1.19

0.86

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

531

1.23

0.85

1.0

314.67

316.23

ng/l

0.02

381

(3008536) Aspergillus sp Ab [Presence] in Serum

204

1.37

0.84

2.1

2.5

—

(3019174) dRVVT (LA screen)

129

1.47

0.83

1.1

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

205

1.37

0.83

2.3

2.6

96.38

31.38

mg/l

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

292

1.30

0.82

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

232

1.34

0.80

1.2

1.4

118.65

97.85

mu/l

0.10

182

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

427

1.24

0.80

4.4

3.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1077

0.85

0.80

1.5

1.4

35.68

31.34

nmol/l

0.53

988

(3052592) Norovirus Ag [Presence] in Stool

181

1.38

0.79

1.2

1.3

—

(3007733) Chloride [Moles/volume] in Urine

1.82

0.79

4.0

1.5

101.17

83.00

mmol/l

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1008

10541

0.95

0.79

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

286

2624

1.09

0.76

1.5

0.45

0.42

nmol/l

0.12

202

2114

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.64

0.75

1.5

1.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

218

1.33

0.74

1.3

1.5

12.21

13.28

g/l

0.23

165

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1248

12015

1.04

0.73

7.6

6.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

316

1.27

0.73

1.2

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

216

1962

1.10

0.72

1.4

7.22

6.88

mmol/l

0.95

196

1767

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.61

0.72

8.1

5.4

—

(3035880) pH of Pleural fluid

398

1.23

0.71

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

372

1.24

0.70

3.2

3.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.55

0.69

1.9

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

230

1.30

0.69

9.1

6.8

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.53

0.68

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

187

1695

1.10

0.67

3.7

33.97

28.56

u/ml

0.26

177

1641

(40757373) Influenza virus identified in Isolate

188

1.33

0.66

1.7

1.5

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

145

1.38

0.65

1.2

1.4

56.20

61.81

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

268

1.27

0.65

1.9

1.5

0.21

0.23

nmol/l

0.10

187

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

313

1.25

0.64

1.2

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

120

1.42

0.64

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

797

0.85

0.64

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

468

1.20

0.64

1.1

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

468

1.20

0.64

1.1

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

246

2267

1.09

0.63

4.2

3.2

20.32

26.43

mg/l

2.72

151

1397

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

207

1.30

0.63

1.9

4.4

174.52

63.42

u/l

0.43

201

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

332

1.24

0.63

1.8

1.7

—

(3000034) Microalbumin [Mass/volume] in Urine

103

906

1.14

0.63

3.0

2.9

43.98

61.91

mg/l

0.53

667

(3051101) Glucose [Moles/volume] in Cord blood

138

1.38

0.62

5.0

6.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.59

0.61

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.60

0.61

1.6

1.7

—

(3048879) Bone marrow aspiration report

226

1.28

0.61

2.4

2.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

130

1.39

0.61

1.7

1.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

113

1.42

0.61

1.6

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

119

1060

1.12

0.60

1.5

1.8

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.60

0.0

1.1

—

0.01

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.57

0.60

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

165

1.33

0.60

4.9

4.5

40.19

38.29

ug/min

0.06

118

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

122

1.39

0.59

1.2

1.4

24.00

15.25

nmol/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

308

1.23

0.59

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

307

2865

1.07

0.59

1.4

1.5

85.58

120.75

pmol/l

1.87

296

2788

(3013336) Amino acids [Identifier] in Serum or Plasma

1.56

0.58

1.7

2.7

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

1.67

0.56

1.2

1.1

347.83

377.36

pmol/l

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

159

1.32

0.55

1.1

—

(3044007) Cell count panel - Peritoneal fluid

248

1.25

0.55

2.3

2.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

598

1.15

0.54

3.4

3.5

7.86

mg/l

0.00

483

(3029612) Listeria sp Ab [Titer] in Serum

1.54

0.53

1.7

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

1.54

0.53

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.52

0.52

1.0

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

223

1.26

0.52

1.4

1.92

2.45

0.34

191

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

232

1.25

0.52

1.2

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.50

0.51

1.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

126

1.35

0.51

2.8

3.4

11.22

7.54

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

658

1.14

0.51

1.7

1.6

4.01

6.63

u/l

2.37

542

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.49

0.49

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

252

1.23

0.49

8.8

6.7

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.49

0.47

1.0

1.1

0.03

mg/l

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

776

1.12

0.47

1.3

1.5

5.45

5.47

mmol/l

0.08

732

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

438

1.16

0.47

1.3

1.5

14.24

14.68

pmol/l

0.26

371

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.46

0.46

1.4

1.3

291.17

534.33

nmol/l

—

(3029396) Erythrocyte agglutination [Presence] in Blood

560

1.14

0.46

3.2

3.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

1.35

0.46

1.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.43

0.46

2.1

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.43

0.45

1.0

1.1

8.00

12.62

u/l

0.52

(3010375) cycloSPORINE [Mass/volume] in Blood

553

1.14

0.44

25.7

26.9

140.90

119.15

ug/l

1.26

459

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

275

1.20

0.43

1.4

41.74

63.72

2.53

226

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.56

0.42

1.0

1.1

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

2.40

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.33

0.40

17.6

5.7

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

287

1.19

0.40

1.1

1.4

47.32

52.92

0.32

240

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

170

1584

1.07

0.40

1.2

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

421

4395

0.96

0.39

1.4

1.5

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.39

0.0

2.3

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

188

1.22

0.37

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.30

0.37

5.8

1.8

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

432

4498

0.96

0.37

1.4

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

216

1.20

0.36

2.1

1.5

0.42

0.44

ug/l

0.08

141

(3022475) Manganese [Moles/volume] in Blood

1.36

0.36

1.2

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.27

0.36

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

160

1709

0.94

0.35

1.6

—

(3005033) Fetal Nuchal fold Thickness US

422

4381

0.96

0.33

1.4

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

146

1.23

0.32

2.1

1.6

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

248

1.17

0.31

1.1

1.3

39.38

38.77

0.02

164

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

230

0.83

0.31

1.1

1.2

—

(3015183) Erythrocyte sedimentation rate

723

1.09

0.31

1.3

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

165

1.21

0.31

5.7

7.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.33

0.30

1.8

1.5

387.30

323.71

umol/24h

—

(3006598) pH of Arterial cord blood

207

0.82

0.30

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.31

0.30

8.3

4.6

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.32

0.28

1.0

1.1

11.28

9.90

mg/l

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.29

0.28

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

490

4754

1.03

0.27

1.5

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

168

1593

1.06

0.27

1.6

7.93

7.64

mmol/l

1.09

161

1534

(3021162) Amylase [Enzymatic activity/volume] in Specimen

168

1.19

0.27

3.2

3.0

325.70

2901.81

u/l

1.86

155

(3023487) Leukocytes [#/volume] in Peritoneal fluid

309

1.13

0.26

2.3

2.2

1109.33

3432.96

e6/l

0.44

215

(3000285) Sodium [Moles/volume] in Blood

113

1.24

0.26

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

510

0.90

0.26

1.2

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.67

0.25

1.4

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

123

1.22

0.25

1.4

20.75

10.18

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

105

1.24

0.24

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

142

1.20

0.24

2.6

1.9

—

(40765096) Chromosome analysis panel by Banding

274

1.13

0.24

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.28

0.23

1.6

1.2

258.80

299.41

nmol/l

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

162

1.17

0.22

3.4

3.0

—

(40768800) Prostate Pathology biopsy report

127

1339

0.95

0.22

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

200

1.15

0.22

2.2

2.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

772

7873

0.98

0.22

1.7

1.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

295

1.12

0.22

1.1

1.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.22

0.22

3.2

2.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

116

1.21

0.22

1.0

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

1.16

0.21

1.0

—

(40760410) HLA-B [Type] by High resolution

1.16

0.21

1.0

—

(40763590) HLA-DQ beta [Type]

1.16

0.21

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.16

0.21

1.0

—

(40758358) Immune stain study

1.16

0.21

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

126

1.19

0.21

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

134

0.82

0.20

1.2

3.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.25

0.20

1.2

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.22

0.20

1.7

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

521

0.92

0.20

1.1

111.17

82.38

u/l

0.87

477

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

713

1.07

0.19

5.3

6.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

593

0.93

0.19

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

174

1.15

0.19

1.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

109

1.19

0.18

1.2

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.21

0.18

1.3

2.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

518

0.93

0.18

1.1

44.08

22.28

u/l

0.61

473

(40761995) Spermatozoa Progressive [#/volume] in Semen

454

0.92

0.16

3.4

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

453

0.93

0.16

6.9

6.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.10

0.15

1.0

1.1

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

336

1.07

0.12

1.8

1.7

—

426.13

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

539

5466

0.99

0.11

1.4

—

(3022689) Creatine [Moles/volume] in Urine

292

0.92

0.11

1.6

1.4

—

(3025577) Chromium [Mass/volume] in Blood

445

1.06

0.11

2.1

2.0

1.39

2.55

ug/l

3.39

380

(3013862) HLA-DP [Type]

1.14

0.10

1.0

—

(3034426) Prothrombin time (PT)

457

1.05

0.09

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

457

1.05

0.09

2.1

2.0

1.56

3.52

ug/l

4.44

413

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

126

1.11

0.09

6.9

3.0

—

(3022670) pH of Venous cord blood

0.79

0.08

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

543

5486

0.99

0.08

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.86

0.07

1.5

1.1

—

(4281824) Cell count and differential, peritoneal fluid

117

1143

1.02

0.07

1.1

1.2

—

(3001729) Color of Synovial fluid

0.86

0.07

1.0

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

545

5498

0.99

0.07

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

104

0.87

0.06

1.0

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

197

1.07

0.06

2.1

2.3

7.51

7.53

mmol/l

0.01

107

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

545

5493

0.99

0.06

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

564

1.03

0.05

7.3

6.2

425.37

6202.91

u/ml

0.54

116

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

179

1.06

0.05

1.4

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

160

1.06

0.04

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

348

1.03

0.04

2.0

2.3

123.82

120.21

ng/l

0.06

215

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

585

5880

0.99

0.04

1.4

1.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

428

1.03

0.03

1.3

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

149

0.94

0.03

7.1

6.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

241

1.04

0.02

2.4

2.5

—

(46235168) Fasting glucose [Moles/volume] in Blood

157

0.96

0.01

3.7

1.2

8.36

7.52

mmol/l

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

233

1.03

0.01

1.5

1.9

2.02

3.35

ug/l

0.51

132

(3008607) Semen analysis panel

126

0.95

0.00

1.3

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

116

1.03

0.00

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

174

0.98

0.00

1.2

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

254

0.98

0.00

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

158

1.01

0.00

1.1

—

(40758292) HTLV I+II Ab panel - Serum

218

1.01

0.00

1.5

1.3

—

(3045462) Protein/Creatinine [Ratio] in Urine

195

1.03

0.00

3.5

5.0

2199.37

60.63

g/mol

0.47

175

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

277

1.01

0.00

2.5

1.9

10168.82

15636.35

e6/l

0.21

152

(3002331) Protein [Mass/volume] in Peritoneal fluid

187

1.02

0.00

1.4

19.13

25.81

g/l

1.20

141

(3030703) Everolimus [Mass/volume] in Blood

0.00

0.0

15.2

—

6.14

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.98

0.00

1.3

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

2.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

1.82

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.94

-0.00

1.0

1.1

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

7.7

—

12.67

—

(4212803) Bone marrow aspirate examination

0.89

-0.00

1.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.95

-0.00

2.2

3.1

—

0.00

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

21.13

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.00

-0.00

1.2

1.4

53.14

73.52

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.00

-0.00

1.0

1.3

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.3

—

21.17

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

30.35

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES – Other and unspecified effects of external causes

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other and unspecified effects of external causes

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other and unspecified effects of external causes (ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints